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Abstract
SOX2 is a master regulator of both pluripotent embryonic stem cells (ESCs) and multipotent neural progenitor cells (NPCs);
however, we currently lack a detailed understanding of how SOX2 controls these distinct stem cell populations. Here we
show by genome-wide analysis that, while SOX2 bound to a distinct set of gene promoters in ESCs and NPCs, the majority
of regions coincided with unique distal enhancer elements, important cis-acting regulators of tissue-specific gene
expression programs. Notably, SOX2 bound the same consensus DNA motif in both cell types, suggesting that additional
factors contribute to target specificity. We found that, similar to its association with OCT4 (Pou5f1) in ESCs, the related POU
family member BRN2 (Pou3f2) co-occupied a large set of putative distal enhancers with SOX2 in NPCs. Forced expression of
BRN2 in ESCs led to functional recruitment of SOX2 to a subset of NPC-specific targets and to precocious differentiation
toward a neural-like state. Further analysis of the bound sequences revealed differences in the distances of SOX and POU
peaks in the two cell types and identified motifs for additional transcription factors. Together, these data suggest that SOX2
controls a larger network of genes than previously anticipated through binding of distal enhancers and that transitions in
POU partner factors may control tissue-specific transcriptional programs. Our findings have important implications for
understanding lineage specification and somatic cell reprogramming, where SOX2, OCT4, and BRN2 have been shown to be
key factors.
Citation: Lodato MA, Ng CW, Wamstad JA, Cheng AW, Thai KK, et al. (2013) SOX2 Co-Occupies Distal Enhancer Elements with Distinct POU Factors in ESCs and
NPCs to Specify Cell State. PLoS Genet 9(2): e1003288. doi:10.1371/journal.pgen.1003288
Editor: Gregory S. Barsh, Stanford University School of Medicine, United States of America
Received June 22, 2012; Accepted December 15, 2012; Published February 21, 2013
Copyright:  2013 Lodato et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NRSA F32-HL104913 (JAW), NIH R01-GM089903 (EF), NIH 5-R37HD045022 and R01-CA084198 (RJ), and the Richard and
Susan Smith Foundation (LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jaenisch@wi.mit.edu (RJ); lboyer@mit.edu (LAB)
. These authors contributed equally to this work.
Introduction
Transcription factors bind DNA in a sequence-specific manner
and regulate gene expression patterns in response to developmen-
tal cues. Thus, transcription factors often direct a hierarchy of
events controlling cellular identity [1,2]. The HMG box contain-
ing transcription factor SOX2 is essential for the development of
the epiblast in the early mammalian embryo [3] and for the
maintenance of embryonic stem cells (ESCs) in vitro [4]. SOX2 is
also necessary for the function and maintenance of neural
progenitor cells (NPCs) in the nervous system [5,6]. Further,
SOX2 functions in other adult stem cell and progenitor
populations in the gastrointestinal and respiratory tract, as well
as in the developing lens, inner ear, taste buds, and testes [7–12].
Thus, SOX2 is a critical regulator of distinct stem cell states, but
how it can serve this multifunctional role is not fully understood.
In ESCs, SOX2 is a component of the core transcriptional
regulatory circuitry that controls pluripotency. Together with
OCT4 (Pou5f1) and NANOG, SOX2 binds to the proximal
promoters of large cohort of genes with known roles in
pluripotency (including Oct4, Sox2, and Nanog) as well as those
that function later in development [13–16]. These data suggest
that SOX2 regulates ESC state by actively promoting pluripotency
and by marking the regulatory regions of developmental genes for
future activation. Consistent with this, SOX2 can act as a pioneer
factor at a subset of genes in ESCs, and can be sequentially
replaced by other SOX family members during differentiation,
leading to activation of genes [17,18]. SOX2 is also a critical factor
in somatic cell reprogramming, whereby adult cells are converted
into a pluripotent ESC-like state by the exogenous expression of a
small set of transcription factors [19–21], with SOX2 being at the
top of a gene expression hierarchy during the late phase of
reprogramming [22].
In the central nervous system (CNS), Sox2 is required for proper
NPC function during embryonic development and for mainte-
nance of NPCs postnatally [23–25]. Specifically, loss of Sox2 in the
developing CNS leads to multiple brain defects, including
precocious progenitor differentiation and a reduced proliferating
cell population in the brain, resulting in perinatal lethality
[5,6,26,27]. In contrast, forced expression of Sox2 blocks terminal
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differentiation of NPCs [26–29]. While a critical role for Sox2 in
distinct stem cell populations has been firmly established both in
vivo and in vitro, the molecular mechanisms by which SOX2
regulates cell type-specific gene expression programs are not clear.
Analysis of genome-wide binding profiles indicates that SOX2
occupies the promoters of thousands of genes [17,30], however, a
direct comparison of SOX2 targets in ESCs and NPCs has not
been reported. Emerging evidence indicates that transcription
factors drive tissue specific gene expression programs through
interactions with distal enhancer elements [31–33]. Recent studies
have shown that histone modification patterns, specifically
monomethylation of lysine 4 of histone H3 (H3K4me1) and
acetylation of lysine 27 on histone H3 (H3K27ac), mark distal
enhancers [34–37]. Using this set of histone marks, we previously
identified thousands of enhancer elements in ESCs and NPCs
[34]. Thus far, the binding of SOX2 at enhancers has only been
clearly demonstrated at a few genes in both ESCs and NPCs. For
example, SOX2 occupies the proximal and distal enhancers
upstream of the Oct4 promoter in ESCs whereas binding at an
intronic enhancer (Nes30) in the Nestin gene was observed in NPCs
[14,38–40]. Thus, knowledge of SOX2-bound enhancers in these
two cell types will contribute significant new insights into
understanding control of cell state.
SOX family members weakly bind DNA and cannot robustly
activate transcription alone, suggesting roles for additional partner
factors in target selection [41]. Consistent with this, cooperation
between SOX and POU transcription factor families has been
highly conserved across metazoans where these factors are
important regulators of developmental programs [42]. For
example, SOX2 cooperates with the Class V POU family member
OCT4 in ESCs to maintain pluripotency [13–16], however
transcription factors that function with SOX2 genome-wide in
NPCs are largely unknown. Thus, the identification of factors that
bind to genomic sites with SOX2 will also be key to understanding
how this master regulator can control distinct phenotypic
outcomes.
Here, we defined the genome-wide binding patterns of SOX2 in
ESCs and NPCs and show that SOX2 occupied a largely distinct
set of genomic regions within promoters and distal enhancer
elements in the two cell types. Similar to its cooperation with
OCT4 (Pou5f1) in ESCs, we identified the Class III POU
transcription factor BRN2 (Pou3f2) as a candidate SOX2 partner
factor that co-bound a large fraction of distal enhancers with
SOX2 in NPCs. Consistent with a functional role, forced
expression of BRN2 in differentiating ESCs led to recruitment of
SOX2 to a subset of NPC distal enhancers. This recruitment was
associated with changes in chromatin structure, activation of
neighboring genes, and ultimately precocious differentiation
toward a neural-like state. Further analysis of bound sequences
showed differences in the arrangement of a SOX-POU binding in
ESCs and NPCs and revealed enrichment for additional
transcription factor motifs. Together, these data reveal new
insights into how SOX2 can function in a context-dependent
manner to specify distinct stem cell states. Our work also has
important implications for understanding development as well as
the process of somatic cell reprogramming.
Results
SOX2 occupies distinct genomic regions in ESCs and
NPCs
SOX2 is a master regulator of pluripotent ESCs and
multipotent NPCs, yet how the same transcription factor can
specify distinct stem cell states remains an open question. We
reasoned that detailed analysis of genomic binding patterns in the
two cell types might reveal how SOX2 can regulate diverse gene
expression programs. To this end, we differentiated ESCs toward
NPCs using established protocols [43], and interrogated SOX2
binding sites by chromatin immunoprecipitation followed by
massively parallel sequencing (ChIP-Seq). Analysis of SOX2
binding in genetically identical ESC and NPC lines identified
13,717 and 16,685 enriched regions, respectively (Table S1). Our
results were highly consistent with prior work in ESCs [16],
however we observed a lower correlation compared to published
data sets in neural progenitor cells (Figure S1A and Discussion).
We found that .95% of bound regions are unique to each cell
type (only 1,274 of the total regions are common to both datasets)
(Figure 1A and Figure S1A, S1B). Thus, we identified a union set
of 29,128 enriched regions at high confidence and found that
SOX2 occupied a largely non-overlapping set of genomic sites in
ESCs and NPCs.
SOX2 is thought to bind to regulatory regions of genes with
roles in stem cell maintenance and neural differentiation [13–16],
however, a direct comparison of genome-wide binding in ESCs
and NPCs has not been reported. Thus, we first mapped binding
sites within 1 kb of a transcription start site (TSS) and found that
SOX2 occupied 893 and 3,821 sites within promoters in ESCs and
NPCs, respectively (Table S2). While ,one-third (36%) of bound
TSSs in ESCs were common to NPCs, SOX2 largely occupied
distinct sites within promoters in the two cell types (Figure S1C).
For example, SOX2 occupied the Nanog promoter only in ESCs,
while the Egr2 (Krox20) promoter was bound only in NPCs, and a
site within the Hdac9 promoter was occupied in both cell types
(Figure 1B). Nanog and Egr2 are critical regulators of the ESC state
and neural development, respectively, and Hdac9 is a broadly
expressed chromatin regulator with a known role in brain
development [44–48]. Furthermore, we also found examples
where SOX2 occupied different sites in ESCs and NPCs but
within the promoters of the same gene, such as the Rlim promoter,
which encodes a regulator of both X-inactivation and later neural
patterning [49,50] (Figure 1B). Consistent with this, while roughly
one-third of TSS-associated regions overlapped in ESCs and
Author Summary
In mammals, a few thousand transcription factors regulate
the differential expression of more than 20,000 genes to
specify ,200 functionally distinct cell types during
development. How this is accomplished has been a major
focus of biology. Transcription factors bind non-coding
DNA regulatory elements, including proximal promoters
and distal enhancers, to control gene expression. Emerg-
ing evidence indicates that transcription factor binding at
distal enhancers plays an important role in the establish-
ment of tissue-specific gene expression programs during
development. Further, combinatorial binding among
groups of transcription factors can further increase the
diversity and specificity of regulatory modules. Here, we
report the genome-wide binding profile of the HMG-box
containing transcription factor SOX2 in mouse embryonic
stem cells (ESCs) and neural progenitor cells (NPCs), and
we show that SOX2 occupied a distinct set of binding sites
with POU homeodomain family members, OCT4 in ESCs
and BRN2 in NPCs. Thus, transitions in SOX2-POU partners
may control tissue-specific gene networks. Ultimately, a
global analysis detailing the combinatorial binding of
transcription factors across all tissues is critical to under-
stand cell fate specification in the context of the complex
mammalian genome.
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
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NPCs, 58% of the genes bound by SOX2 in ESCs were also NPC
targets (Figure 1B, Figure S1C and S1D). These data suggest that
SOX2 can utilize different binding sites to regulate genes in a
context-dependent manner.
On a global level, SOX2 bound to a set of genes that code for
chromatin and transcriptional regulators in both ESCs and NPCs
in accordance with previous data [13–16] (Figure 1C, 1D and
Table S3). While many of these targets were common to both cell
types, a large group of chromatin and transcriptional regulators
(490) were occupied uniquely in NPCs. Moreover, SOX2 bound
more promoter regions in NPCs compared to ESCs and also
occupied genes with diverse functions such as RNA splicing,
regulation of the ubiquitin cycle, and translation (Figure 1D).
While RNA splicing is a general cellular function, alternative
splicing is known to play a key role in brain development [51]. For
example, in NPCs, SOX2 occupied the promoters of the
alternative splicing factors PTB and nPTB, which constitute a
molecular switch regulating neuronal commitment [52]. We also
found that SOX2 occupied genes displayed higher expression
compared to all genes (Figure 1E, 1F and Table S4) suggesting that
SOX2 has a positive regulatory role at promoters in each cell type.
SOX2 binds to distal enhancer elements in ESCs and
NPCs
While SOX2 occupied proximal promoter regions in the two
cell types, the vast majority of bound sites (.93% and .77% in
Figure 1. SOX2 binds promoters with cell-type-specific functions in ESCs and NPCs. (A) Heat maps of SOX2 enrichment in ESCs and NPCs
centered on peaks of enrichment and extended 4 kb in each direction. (B) Gene plots showing SOX2 density at Nanog, Erg2, Hdac9, and Rlim in ESCs
(blue) and in NPCs (red). y-axis corresponds to reads per million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). (C, D) GOstat gene
ontology analysis of genes linked to SOX2 bound TSSs. x-axis corresponds to negative log base ten p-value of enrichment of genes in target list
compared to a whole genome background set. (E, F) Box and Violin plots representing expression data from Affymetrix arrays of genes linked to
SOX2 target TSSs. y-axis corresponds to percentile expression rank, * denotes p-value,0.01, Student’s T-test, two tailed.
doi:10.1371/journal.pgen.1003288.g001
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ESCs and NPCs, respectively) mapped greater than 1 kb from
annotated TSSs (Figure 2A). Distal enhancers are important non-
coding DNA elements that control tissue specific gene expression
patterns at variable distances from the promoters they regulate
through binding of transcriptional and chromatin regulators [31–
33]. We previously identified thousands of putative enhancers in
ESCs and NPCs by genome-wide analysis of H3K4me1 and
H3K27Ac occupancy, two histone marks known to mark distal
enhancer elements [34]. SOX2 bound ,17% (4,947) and ,24%
(6,842) of these putative enhancers in ESCs and NPCs,
respectively (Figure 2B and Table S2). Currently, distal enhancers
are presumed to regulate the nearest gene [34,37], and after
assigning each enhancer to the nearest upstream or downstream
gene, we found that the SOX2-bound enhancers corresponded to
3,372 and 3,990 genes in ESCs and NPCs, respectively (Table S2).
While these sites were largely distinct in the two cell types (Figure
S2A), ,44% of genes associated with SOX2 enhancers in ESCs
also had a bound enhancer assigned to the same gene in NPCs
(Figure S2B) and included many factors with specific roles in
neural specification. Notably, analysis of bound enhancers
revealed thousands of additional genes that may be regulated by
SOX2 in both cell types which would not have been identified by
analysis of only TSSs (Figure S2C, S2D). These data are consistent
with the idea that, while enhancer utilization is highly cell type-
specific, individual genes can be regulated by different enhancers
[31,53].
The pattern of H3K4me1 and H3K27Ac occupancy can
distinguish a given enhancer as active (H3K4me1+/2;
H3K27Ac+) or poised (H3K4me1+; H3K27Ac2), states which
correlate with high expression of a neighboring gene or the
potential of that gene to be expressed later during development,
respectively [34,37,54,55]. Thus, globally genes nearest active
enhancers are expressed at a higher level than those linked to
poised elements. By comparison of SOX2-bound regions with the
set of active and poised enhancers in our previous study [34], we
found that SOX2 occupied 2,100 and 4,037 poised enhancers and
2,847 and 2,805 active enhancers in ESCs and NPCs, respectively
(Table S2). Consistent with the idea that enhancers regulate
transcriptional output, expression of genes closest to SOX2-bound
active enhancers is significantly higher than genes associated with
SOX2-bound poised enhancers (Figure 2C).
To gain deeper biological insights, we used the GREAT
algorithm to perform Gene Ontology (GO) analysis to determine
the function of genes associated with SOX2-bound enhancers.
SOX2-bound poised enhancers in ESCs were nearest genes that
function in commitment to the neural lineage and morphogenesis
and included Jag1, Neurog3, and Nkx2-2, whereas those associated
with poised enhancers in NPCs included genes with roles in
terminal differentiation into neurons and glia such as Atoh1, Lhx8,
Id2 and Id4 (Figure 2D, Tables S5 and S6). Notably, SOX2 bound
to active enhancers nearest genes with functions in stem cell
development in both cell types. Enriched categories in ESCs also
revealed genes that function in early development and axis
specification whereas genes linked to active enhancers in NPCs
have roles in WNT signaling and neurogenesis (Figure 2E). For
example, SOX2 occupied a known enhancer in the 59 region of
the Nanog locus in ESCs [56] and bound to intronic enhancers in
Notch1 in NPCs [57,58], known regulators of pluripotency and
neurogenesis, respectively (Figure 2F). Thus, we identified
thousands of stage-specific enhancers including many previously
known enhancers in both cell types.
Despite the low overlap of SOX2-bound enhancer regions in
ESCs and NPCs, genes linked to SOX2-bound poised enhancers
in ESCs had functions in neural development, similar to genes
linked to SOX2-bound enhancers in NPCs. Thus, we hypothe-
sized that SOX2 might be regulating a subset of targets in both cell
types by occupying distinct enhancer elements. Indeed, direct
comparison of these genes revealed that ,50% of genes (821 of
1,654) associated with SOX2-bound poised enhancers in ESCs
also had a bound enhancer associated with that gene in NPCs
(Figure S2E), despite the regions of SOX2 binding being largely
cell-type specific. Importantly, genes where enhancers remained
poised showed no significant difference in expression whereas
those genes that gained active enhancers were expressed at higher
levels (Figure S2F). These data are consistent with the idea that,
while enhancer utilization is highly cell type-specific, individual
genes can be regulated by different enhancers [31,53]. Along those
lines, using the GREAT algorithm to query the MGI gene
expression database, we determined that 2,253 of the 4,037
SOX2-bound poised enhancers in NPCs were linked to genes
expressed in the postnatal mouse nervous system (binomial p-
value = 1.91e-35) (Table S6). Together, our data support the idea
that poised enhancers can predict future developmental potential
and suggest that SOX2 regulates a larger network of genes than
previously anticipated by binding to distal enhancer elements.
BRN2 co-occupies distal enhancers with SOX2 in NPCs
SOX2 binds DNA weakly and it is insufficient to strongly
activate transcription without cooperation with additional factors
[59]. Consistent with this idea, we identified the canonical SOX2
motif, 59-CTTTGTT-39 [60–63] as highly enriched in ESCs and
NPCs despite the difference in binding patterns (Figure 3A). Thus,
we sought to identify additional factors that may function with
SOX2 in ESCs and NPCs. SOX2 partners with the Class V POU-
domain containing transcription factor OCT4 in ESCs to regulate
a large cohort of genes important for pluripotency [13–16]
however, partner factors in NPCs have not been clearly defined.
Interactions between SOX and POU factors are conserved in
all metazoans and play key roles in embryonic development [42],
thus, we hypothesized that SOX2 may also function with POU
factors in NPCs. To test this, we interrogated a 100 bp window
surrounding peaks of SOX2 enrichment in NPCs and determined
enrichment for all known vertebrate transcription factor-binding
motifs in the TRANSFAC database. Notably, we identified several
enriched motifs, including two highly similar motifs recognized by
the Class III POU factor BRN2 (Pou3f2) (Figure 3B and Table S7).
BRN2 was of particular interest for several reasons. First, our
transcriptome analysis showed that Brn2 is highly expressed in
NPCs, but not in ESCs (Table S7). Moreover, Brn2 and Sox2 are
both expressed in neurogenic regions of the brain and SOX2 and
BRN2 are known to co-occupy a small number of loci in this tissue
[38,64,65]. Like Sox2, Brn2 loss-of-function causes pleiotropic
defects and NPC impairment [66–69]. Furthermore, Sox2, Brn2,
and the forkhead transcription factor Foxg1 are sufficient to
reprogram fibroblasts toward a multipotent NPC-like state [70].
These data suggest that transitions in POU partner factors of
SOX2 may control cell identity in distinct stem cell populations.
Although neurogenesis and maintenance of cell identity in the
brain require BRN2, its target genes in NPCs were not known. To
address this, we performed ChIP-Seq and identified 6,574 BRN2
occupied regions in NPCs (Table S1). Similar to SOX2-bound
regions, more BRN2-bound regions mapped to previously
identified distal enhancers [34] than to promoter regions (Figure
S3A). Motif analysis revealed enrichment for a canonical Octamer
(OCT) motif (59-ATGCATAT -39) [71,72] within BRN2 bound
sites validating the high quality of our data set (Figure S3B).
We next examined the overlap between SOX2 and the two
POU factors (BRN2 and our previously published OCT4-ESC
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
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dataset [16], Table S1) in ESCs and NPCs. Regions occupied by
OCT4 and BRN2 showed little overlap (Figure S3C), indicating
that these factors occupied cell-type-specific targets. Our data
confirmed that SOX2 and OCT4 co-occupied many genomic sites
in ESCs [13–16] (Figure 3C and Figure S3D-S3G). For example,
SOX2 and OCT4 co-bound the promoter of Fbxo15 and to two
putative enhancers of Pax6 that have been previously identified
based on evolutionary sequence conservation and histone modi-
fication patterns [73] (Figure 3D). Notably, whereas BRN2 was
absent from most SOX2-bound promoters in NPCs (Figure 3E),
Figure 2. SOX2 binds distinct enhancer regions in ESCs and NPCs. (A) SOX2 peaks mapping to annotated transcriptional start sites,
intragenic regions, and intergenic regions. Numbers on pie chart indicate fraction of bound regions that fall into each category. (B) Fraction of total
start sites or total marked enhancers associated with SOX2 enriched regions. Numbers above bars reflect absolute numbers of bound regions and
genomic features. (C) Box and Violin plots representing expression data from Affymetrix arrays of genes linked to SOX2-bound poised and active
enhancers. y-axis corresponds to percentile expression rank, * denotes p-value,0.01, Student’s T-test, two tailed. (D, E) Analysis of GO biological
processes enriched in SOX2 bound poised and active enhancer datasets in ESCs and NPCs. x-axis reflects negative log base 10 of binomial raw p-value
for enrichment versus a whole genome background. (F) Gene plots showing SOX2, H3K4me1, and H3K27Ac density at Nanog in ESCs and Notch1 in
NPCs. y-axis corresponds to reads per million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). Gray boxes indicate putative enhancers
occupied by SOX2. * denotes known enhancer region.
doi:10.1371/journal.pgen.1003288.g002
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
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Figure 3. BRN2 co-occupies distal enhancers with SOX2 in NPCs. (A) de novo MEME motif analysis of SOX2 bound regions in ESCs and NPCs
revealed canonical SOX2 motif. (B) TRANSFAC BRN2 motifs enriched in SOX2 target regions in NPCs. p-values represent significance of enrichment
based on Mann-Whitney Wilcoxon ranked sum test with Benjamini-Hochberg multiple hypothesis testing correction. (C) Heat maps of SOX2 and
OCT4 at SOX2 bound promoters and enhancers centered on peaks of SOX2 enrichment and extended 4 kb in each direction. (D) Gene plots showing
SOX2, OCT4, H3K4me1, and H3K27Ac density at the Fbxo15 promoter and at poised enhancers of Pax6 in ESCs. y-axis corresponds to reads per
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
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BRN2 occupied a subset of distal enhancers and bound many of
these sites with SOX2, including known SOX2-BRN2 targets such
as enhancers of Sox2 and Nestin [38,65] (Figure S3H-S3K). For
example, SOX2 and BRN2 co-occupied putative 39 enhancer
regions of Olig1 [74], and a known regulatory region 39 of the Ascl1
(Mash1) locus [75] (Figure 3F). Together, these data suggest that
SOX2 functions with BRN2 at a subset of distal enhancers to
regulate target genes in NPCs.
Whereas SOX2-OCT4 bound enhancers associated with genes
that have roles in pluripotency and lineage commitment, SOX2-
BRN2 enhancers neighbored genes that function in NPC identity.
Overall, SOX2 and BRN2 occupied 756 poised and 895 active
enhancers in NPCs (Figure 3G). SOX2-BRN2 bound active
enhancers correlated with genes that were expressed at higher
levels than those associated with poised enhancers (Figure 3H).
Further analysis revealed genes linked to active enhancers included
transcription factors that play roles in neural development such as
Notch1, Rfx4 and Sox2 itself (Figure 3I and Table S8). Interestingly,
genes linked to the co-bound poised enhancers in NPCs included
regulators of later stages of neuronal developmental such as the
pro-neural transcription factor Atoh1 [76,77] and Dab1, a critical
regulator of neuroblast migration [78] (Figure 3J and Table S8).
Notably, ,24% of genes associated with SOX2-OCT4 poised
enhancers in ESCs overlapped with genes associated with SOX2-
BRN2 bound enhancers in NPCs that included known regulators
of neural development such as Atoh1 and Ncam1, despite
differences in the bound regions. Thus, SOX2-POU partnerships
may control neural development by differentially targeting specific
subsets of enhancers in pluripotent ESCs and multipotent NPCs,
in order to establish the development potential of this tissue from
very early stages of embryogenesis.
BRN2 expression in ESCs promotes neural differentiation
The significant overlap between BRN2 and SOX2 in NPCs
predicts that BRN2 is also an important driver of neural
commitment. To test this idea, we generated ESC lines that
harbored a drug-inducible Brn2 transgene (TetO-Brn2) and
assayed the potential of these cells to differentiate toward the
neural lineage (Figure S4A–S4C). Upon Brn2 induction, ESCs
showed distinct morphological changes from round cells that grew
in colonies to polarized, Nestin-positive cells at day 1 of
differentiation compared to control cells (Figure 4A and Figure
S4D). Consistent with these changes, neural lineage genes such as
Nestin and Sox1 showed higher expression in ESCs upon Brn2
expression (Figure 4B). Notably, Brn2 induction led to changes in
gene expression and cell fate in the absence of additional growth
factors whereas control cells did not show significant differences
under these conditions. Thus, forced expression of Brn2 can
promote differentiation of ESCs toward a neural-like fate.
Our data suggested that POU factor expression may be a key
determinant of cell-type-specific SOX2 target selection, so we
hypothesized that ectopic BRN2 might be sufficient to recruit
endogenous SOX2 to genomic regions de novo. To test this, we
collected TetO-Brn2 cells two days after induction (Figure S4D)
and performed ChIP-Seq. We identified 12,362 and 8,401 regions
occupied by SOX2 and BRN2 in these cells, respectively (Table
S1). Similar to SOX2 and BRN2 in NPCs, these factors occupied
more distal sites than promoters (Figure S4E). Strikingly, ,18%
(1,034 regions) occupied by BRN2 in the induced ESCs were also
bound by BRN2 in NPCs, indicating that ectopic BRN2 retained
some of its NPC target specificity. These regions were distal to loci
encoding neurodevelopmental regulators such as Ephrin Recep-
tors (Epha3, Epha4, Epha5, Epha7) and transcription factors such as
Id2 and Id4 (Table S9).
Importantly, we defined 1,533 regions co-occupied by BRN2
and SOX2 in these cells. Comparison of these regions to SOX2
and OCT4 targets in ESCs and SOX2 in control cells at day 2
(Table S1) revealed 701 (46%) of these sites were bound uniquely
by SOX2-BRN2 in the induced cells. These data suggested that
BRN2 was necessary for SOX2 binding at these sites (Figure 4C
and Figure S4F, S4G). Analysis of enriched GO categories showed
that genes closest to these novel targets had roles in the
development and function of the nervous system (Figure 4D and
Table S9). Notably, 21% of these novel sites (144 regions) were
also bound by SOX2 and/or BRN2 in NPCs, including enhancers
linked to genes with demonstrated roles in neural development
such as Lrrn1 and Abpa2 (X11l) [79–81] (Figure 4E). Expression
analysis by qRT-PCR of a subset of these TetO-Brn2/NPC,
SOX2-BRN2 genes, including Lrrn1, Abpa2, Kirrel3, Cops2, Id4, and
Lemd1, revealed that some were significantly induced in TetO-
Brn2 cells compared to controls (Figure 4F). Thus, ectopic BRN2
was sufficient to recruit SOX2 to NPC-specific sites and to induce
the expression of nearby genes, indicating that POU-factor
partners are sufficient to functionally recruit SOX2 to a subset
of cell-type-specific target loci.
Given that SOX2-BRN2 binding in NPCs correlated with cell-
type-specific distal enhancers, we hypothesize that SOX2-BRN2
might play a role in regulating the state of these elements. Thus,
we next examined the distribution of the enhancer chromatin
marks, H3K4me1 and H3K27Ac, in TetO-Brn2 and control cells
at day 2 in order to determine whether the ectopic binding of these
factors could alter local chromatin structure (Table S1). We found
that 777 of the 1,533 co-bound sites (,51%) were coincident with
H3K4me1 and/or H3K27Ac regions in TetO-Brn2 cells and 488
of these regions (,32%) displayed similar patterns in both induced
and control cells (Figure 4G). Interestingly, 165 of the co-occupied
regions (,11%) gained H3K27Ac upon Brn2 induction, and were
closest to genes involved in neural development such as Atoh1,
NeuroD1, and Tcf7l (Tcf3). This included 125 regions (,8%) that
were unmarked (i.e. lacked H3K4me1 or H3K27Ac) in control
cells (Figure 4H) and 40 regions (,3%) that transitioned from a
poised state to active (Figure 4I). Thus, ectopic BRN2-SOX2
binding was sufficient to activate both poised and unmarked
enhancers, supporting a role for these factors in controlling global
gene expression networks by regulating the activity of cis-
regulatory elements. Collectively, these data support a role for
distinct POU factors in SOX2 binding site selection and gene
million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). Gray boxes indicate regions co-occupied by SOX2 and OCT4. (E) Heatmaps of
SOX2 and BRN2 enrichment at SOX2-bound promoters and enhancers in NPCs centered on peaks of SOX2 enrichment and extended 4 kb in each
direction. (F) Gene plots showing SOX2, BRN2, H3K4me1, and H3K27Ac density at Olig1 and Ascl1 loci in NPCs. y-axis corresponds to reads per million.
Due to the high enrichment of H3K27Ac at active promoters, y-axis was cut off to show full dynamic range of enhancer-associated H3K27Ac density.
Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). Gray boxes indicate regions of SOX2-BRN2 co-occupancy. * indicates known
enhancer. (G) Breakdown of number of SOX2-BRN2 target enhancers that are H3K4me1+, H3K27Ac2 (poised) or H3K4me1+/2, H3K27Ac+ (active). (H)
Box and Violin plots representing expression data from Affymetrix arrays of genes linked to poised and active SOX2-BRN2 target enhancers in NPCs.
y-axis corresponds to percentile expression rank, * denotes p-value,0.01, Student’s T-test, two tailed. (I, J) GREAT analysis of genes linked to poised
and active SOX2-BRN2 target enhancers in NPCs.
doi:10.1371/journal.pgen.1003288.g003
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Figure 4. Brn2 biases ES cells towards neural differentiation. (A) Staining with DAPI (blue) and immunocytochemistry of NESTIN (green) in
ESCs induced to differentiate in adherent cultures with or without ectopic Brn2. (B) qRT-PCR of the indicated genes in ESCs with (black lines) and
without (gray lines) ectopic Brn2 expression through differentiation. y-axis represents relative expression normalized to Gapdh in 3 biological
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regulation, and suggests a model by which BRN2 functions with
SOX2 to mediate developmental transitions in the neural lineage.
Binding configurations of SOX2 and POU factors at
genomic targets in ESCs and NPCs
Given that most SOX and POU family members bind highly
similar motifs, we hypothesized that distinct motif configurations may
explain, in part, the diverse binding patterns in ESCs and NPCs. For
example, SOX2 and OCT4 bind DNA in distinct conformations
depending on the arrangement of binding sites [82–86] and these
configurations have consequences on factor binding and transcrip-
tional outcome [38,82,86,87]. We found that SOX2 frequently
occupied sites within 25-bp of OCT4 (,25%), and that relatively few
sites were greater than 100–200 bp from OCT4 (,8%) (Figure 5A).
In contrast, while a significant fraction of regions showed SOX2 and
BRN2 bound within 25-bp in NPCs (,12%), a larger fraction
(,33%) occurred at distances of 100–200 bp. For example, an
intragenic region of theWwc1 locus was bound by SOX2 and BRN2
in NPCs and peaks of enrichment were 100 bp apart (Figure 5B),
while in ESCs neither SOX2 nor OCT4 recognized this element.
These data indicate that while SOX2 and POU factors occupied
similar motifs in ESCs and NPCs, these factors bound to different
arrangements of these motifs in a cell type-specific manner.
Many known SOX2-OCT4 target sites comprise a composite
SOX-Octamer (OCT) motif, consisting of a 59-SOX motif
followed by a 39 OCT site [15,88,89]. Therefore, we further
analyzed the configuration of the SOX2 and OCT motifs by
directly inspecting the sequence within the co-occupied regions.
SOX-OCT composite motifs can exist in several configurations
that were previously termed ‘‘canonical’’, ‘‘order’’, ‘‘diverging’’,
and ‘‘converging’’ [86] (Figure 5C). Interestingly, these configu-
rations were shown to determine which combinations of SOX and
POU factors could co-occupy a given site. Surprisingly, we
observed that the canonical orientation with a 1 bp overlap
between the native TRANSFAC motifs was the most highly
represented configuration in both SOX2-OCT4 co-bound regions
in ESCs (,23% of motif pairs) and SOX2 and BRN2 co-bound
regions in NPCs (,21% of motif pairs) (Figure 5C). For example,
at a locus on chromosome 2 distal to Chd6, SOX2-OCT4
occupied a canonical motif with a 1 bp overlap in ESCs, and
SOX2-BRN2 occupied the same site in NPCs (Figure 5D). Thus,
SOX2-OCT4 and SOX2-BRN2 prefer the same composite SOX-
OCT motif at genomic targets in ESCs and NPCs.
Distinct SOX-POU sites harbor recognition motifs for
other transcription factor families
Combinatorial interactions among transcription factors are
important for driving specific transcriptional responses [90–93]. In
ESCs, SOX2 and OCT4 are known to co-occupy genomic sites
with a cohort of other transcription factors, including NANOG,
SALL4, and TCF7L1 [13–16,94–96]. Thus, we sought to identify
additional transcription factors that may interact with SOX2 and
BRN2 in NPCs. To this end, we analyzed SOX2-BRN2 bound
regions for enrichment of known transcription factor motifs (Table
S10). To discover factors that may function specifically with SOX2
and BRN2 in NPCs, we contrasted these motifs with those that
were enriched in SOX2-OCT4 co-bound regions. Notably, the
enriched motifs in SOX2-BRN2 regions corresponded to
transcription factors that were highly expressed in NPCs relative
to ESCs (Monte Carlo analysis, p-value = 0.03, Materials and
Methods) (Figure 6A). For example, NF-I motifs were highly
enriched in SOX2-BRN2 regions in NPCs and family members
such as NF-Ia, NF-Ib, and NF-Ix were expressed at significantly
higher level in NPCs than ESCs (Table S10). NF-I factors have
known roles in central nervous system formation and in NPC
function [97]. Motifs associated with the RFX family were also
enriched in SOX2-BRN2 regions (Table S10). RFX family
members play essential roles in early nervous system patterning
[98,99]. While Rfx3, Rfx4, and Rfx7 were expressed at significantly
higher levels in NPCs, Rfx2 expression was higher in ESCs (Table
S10). Interestingly, a recent proteomic study identified RFX3 and
NF-IB as putative SOX2 interaction partners in NPCs [30]. Thus,
our analysis has identified additional transcription factors that may
regulate specialized gene networks with SOX2 and POU factors in
ESCs and NPCs.
We identified 439 SOX2-BRN2-NF-I-motif and 251 SOX2-
BRN2-RFX-motif regions in NPCs (see Materials and Methods).
Further analysis showed that SOX2-BRN2 regions containing NF-
I or RFX motifs were largely exclusive (only 34 common regions)
suggesting that SOX2-BRN2 sites could be further classified by
interactions with specific sets of transcription factors. Consistent
with this observation, SOX2-BRN2 regions containing an NF-I
motif were linked to genes with functions in nervous system
development and cell growth, including Sox2 and NF-Ib themselves
as well as Olig1 and Integrin genes (Figure 6B). In contrast, SOX2-
BRN2-RFX-motif regions were linked to a largely distinct set of
regulators of neural development including regulators of neuronal
apoptosis such as Ntrk2 (TrkB) [100], Ntrk3 (TrkC) [101], and
Cdk5r1 (p35) [102,103], an important process regulating the
development of the CNS (Figure 6C). Interestingly, conditional
ablation of Sox2 in NPCs is associated with increased apoptosis in
the developing brain [6]. Thus, RFX and NF-I family members
represent additional candidate partner factors in NPCs that may
further contribute to specific regulation at SOX2-BRN2 target
genes. Collectively, our work reveals a detailed picture of how
SOX2 coordinates gene expression programs during lineage
replicates, measured in triplicate. ESC time point is ESCs without doxycycline, and d1–d9 time points represent time in differentiationmedium. * denotes
p-value,0.05, ** denotes p-value,0.01 ANOVA with Bonferroni correction (C) Heatmap of OCT4 and SOX2 enrichment in ESCs and ectopic BRN2 and
SOX2 in TetO-Brn2 cells of 701 genomic regions occupied by only ectopic BRN2 and SOX2. (D) GREAT GO biological processes enriched in 701 regions in
(C). x-axis reflects negative log base 10 of raw binomial p-value for enrichment versus a whole genome background. (E) Gene plots depicting peaks of
enrichment in indicated datasets at a locus distal to Lrrn1. y-axis corresponds to reads per million. Genomic positions reflect NCBI Mouse Genome Build
36 (mm8). (F) qRT-PCR of genes associated with SOX2-BRN2 binding in TetO-Brn2 cells and NPCs, in ESCs with (black lines) and without (gray lines)
ectopic Brn2 expression through differentiation. y-axis represents relative expression normalized to Gapdh in 3 biological replicates, measured in
triplicate. ESC time point is ESCs without doxycycline, and d1–d9 time points represent time in differentiation medium. * denotes p-value,0.05, **
denotes p-value,0.01 ANOVAwith Bonferroni correction. (G) Pie chart reflecting overlap between SOX2-BRN2 regions and enhancer chromatinmarks in
TetO-Brn2 cells. Percentages in legend reflect fraction of 1,533 SOX2-BRN2 regions in each category. (H) Example region that was occupied by ectopic
BRN2 in TetO-Brn2 cells, leading to recruitment of endogenous SOX2 and the deposition of H3K4me1 and H3K27Ac. y-axis corresponds to reads per
million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). Gray box indicates region of SOX2-BRN2 co-occupancy in TetO-Brn2 cells which
was not occupied by SOX2 in control cells. (I) Example poised enhancer occupied by ectopic BRN2 in induced cells, leading to recruitment of
endogenous SOX2, and deposition of H3K27Ac. y-axis corresponds to reads per million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8).
Gray box indicates region of SOX2-BRN2 co-occupancy in TetO-Brn2 cells which was not occupied by SOX2 in control cells.
doi:10.1371/journal.pgen.1003288.g004
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commitment and provides novel insights into the key principles
that underpin regulation of diverse stem cell states.
Discussion
The HMG-box transcription factor SOX2 has critical roles in
the function of multiple stem cell types including pluripotent
embryonic stem cells (ESCs) and multipotent neural progenitor
cells (NPCs). How this master regulator can control diverse
transcriptional programs has remained an important and unre-
solved question in the field. While SOX2 occupied many
promoters in both cell types, the major class of genomic elements
occupied by SOX2 in ESCs and NPCs were distal enhancers
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Figure 5. Motif configuration affects binding by SOX2 and cell-type-specific POUs. (A) Frequency distribution of distances in 25 base pair
bins between peaks of OCT4 (top) and BRN2 (bottom) from SOX2 bound peaks. (B) Gene plots at the Wwc1 locus. Direction of transcription (59-39) is
left to right. Hashed line represents position of peaks of SOX2 and BRN2 enrichment separated by 100 bp. y-axis corresponds to reads per million.
Genomic positions reflect NCBI Mouse Genome Build 36 (mm8). (C) Distribution of orientation of and distance in base pairs between of SOX and POU
motifs within SOX2-OCT4 (top), SOX2-BRN2 (bottom) bound regions. Negative values on x-axis reflect instances where SOX and OCT TRANSFAC
motifs overlap. y-axis reflects fraction of occurrences of indicated spacing and orientation of all bound regions which contain a SOX and OCT motif.
(D) Gene plots 39 of the Chd6 locus, which contains a SOX-OCT motif in the canonical orientation with a 21 bp spacer. Hashed line represents
sequence under the peaks of enrichment, and boxed sequence represents the canonical SOX-OCT motif with a 21 bp spacer at this locus. y-axis
corresponds to reads per million. Genomic positions reflect NCBI Mouse Genome Build 36 (mm8).
doi:10.1371/journal.pgen.1003288.g005
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
PLOS Genetics | www.plosgenetics.org 10 February 2013 | Volume 9 | Issue 2 | e1003288
Figure 6. Additional transcription factor motifs are enriched in SOX2-POU-bound regions. (A) Heatmaps display the relationship
between expression changes in transcription factors and the enrichment of their motifs in SOX2-BRN2 bound regions compared to SOX2-OCT4-
bound regions. The full set of TRANSFAC motifs were ranked by statistical significance of enrichment in SOX2-BRN2-bound regions and in SOX2-
OCT4-bound regions using the Mann-Whitney Wilcoxon test. The heat map on the right displays the change in rank of 108 TRANSFAC motifs
between the two datasets. Only motifs that were ranked in the top 200 in either dataset are shown. The heat map on the left shows the fold change
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concordance among replicates and with published data sets in
ESCs, SOX2 binding in NPCs was less correlated with prior data
[17,30] (Figure S1). This is likely due to the different protocols
used to derive and culture NPCs. NPCs with similar developmen-
tal potential but distinct molecular profiles exist throughout
development [24], and these populations respond differently to
external signaling cues present in culture media [104–106]. Thus,
it is perhaps not surprising that SOX2 binding is more variable in
NPCs relative to ESCs.
We derived NPCs directly from genetically identical ESCs
allowing us to directly analyze SOX2 binding as these cells
transition between states. Several criteria support the high quality
of our data. First, we identified many known SOX2 binding sites
including promoters and enhancers in both ESCs and NPCs.
Second, while many binding sites were distinct, we identified a
canonical SOX2 motif as highly enriched in both cell types. Third,
SOX2 overlapped significantly with POU partner factors in ESCs
and NPCs consistent with the expectation that these transcription
factor families function together to regulate developmental
progression. In addition, we identified a SOX-OCT composite
motif as enriched in these co-bound sites.
SOX2 occupied largely exclusive sites in ESCs and NPCs,
despite using the same DNA motif to recognize these genomic
targets. Moreover, SOX2 occupied distinct regions in the same
promoter and distinct enhancers associated with the same gene.
These data indicated that additional factors dictated SOX2
binding site specificity. While SOX2 co-occupied many binding
sites with OCT4 in ESCs, partner factors in NPCs have not been
well defined. We found the recognition motif for the Class III
POU factor BRN2 was enriched in SOX2 bound regions in
NPCs. The evolutionary conservation of the SOX-POU interac-
tion, the co-expression of Sox2 and Brn2 in neurogenic regions of
the brain, and the neurodevelopmental defects associated with
Brn2 loss-of-function suggested that SOX2 and BRN2 together
regulate a subset of genes important for neural fate. Consistent
with this, we defined a large group of enhancer elements co-bound
by SOX2 and BRN2 in NPCs. We identified known functional
enhancers bound by SOX2 and BRN2 in NPCs, such as the Nes30
enhancer of the Nestin locus [38,40] and the 39 enhancer of the
Sox2 locus, SRR2 [5], and extended this list to include hundreds of
additional neural-specific enhancers.
Consistent with a positive role in regulating neural cell state,
forced expression of Brn2 led to up-regulation of neural markers
and to differentiation toward the neural lineage. Our work is in
agreement with several studies that have implicated Brn2 as an
early marker of neural commitment [40,107,108]. Notably,
ectopic BRN2 was sufficient to recruit SOX2 to hundreds of
novel sites in differentiating ESCs that corresponded to a subset of
enhancers also bound in NPCs. The recruitment of SOX2 by
BRN2 to specific loci was sufficient to induce expression of nearby
genes and to alter chromatin state in some cases. These data are in
agreement with the notion that SOX proteins require partner
factors to tightly bind to genomic targets and modulate
transcriptional outcomes [59]. Interestingly, ectopic expression of
OCT4 alone in NPCs was sufficient to reprogram cells into
induced pluripotent stem cells, presumably by partnering with
endogenous SOX2 [109], consistent with the idea that POU
factors can recruit SOX2 to specific targets. Furthermore, ectopic
expression of Sox2, Brn2, and the forkhead factor Foxg1 can
transdifferentiate fibroblasts to NPC-like cells [70]. Taken
together, these data may facilitate efforts to define the minimal
set of genes needed to promote the transition from undifferentiated
cells to the neural lineage. Thus, our results implicate BRN2 as a
SOX2 partner factor and suggest that together these factors are
important for neural specification and NPC function.
While the motifs occupied by these factors were highly similar,
the arrangement of SOX and OCT motifs in SOX2-POU target
sites displayed differences in ESCs and NPCs. Regulation of SOX-
POU target genes appears to depend not only on the presence of a
SOX and an OCT motif in close proximity to each other, but also
on other DNA sequence determinants, including the spacing and
orientation of these motifs with respect to each other
[82,84,87,110–113]. However, these observations related to only
a few genes and had not been extended genome-wide. While we
found that SOX2-OCT4 and SOX2-BRN2 preferred similar
composite motifs when they were bound in close proximity to each
other, examination of co-bound regions found that peaks of SOX2
and BRN2 in NPCs were often spaced farther apart than peaks of
SOX2 and OCT4 in ESCs. Thus, allosteric interactions between
transactivation domains of SOX and POU factors may be key in
stabilizing ternary complexes and in setting the stage for additional
interactions that determine binding specificity and transcriptional
output at target genes [84–87,114,115].
Combinatorial interactions among transcription factors allow
cells to respond to environmental and developmental cues in a
tissue-specific manner. A classical example involves the regulation
of interferon-b expression through cooperative binding of tran-
scription factors and chromatin proteins to an enhancer,
collectively known as the interferon-b enhancesome [116]. In
ESCs, SOX2 and OCT4 are known to physically interact with
other transcription factors at many loci, including enhancers
[14,94,117–120], suggesting that SOX2-POU factors may also
nucleate specific enhancesomes. We identified a set of candidate
factors that may interact with SOX2-BRN2 that included RFX
and NF-I family members. NF-I factors are expressed in NPCs in
vivo and their loss in development leads to defects in central
nervous system formation and specifically NPC dysfunction
[97,121–124]. RFX family members also play essential roles in
proper brain development [99,125]. For example, RFX4 regulates
Sonic Hedgehog (SHH) signaling in the developing nervous system
and loss of function resulted in pleiotropic brain defects linked to
SHH signaling [99,125]. Defects associated with conditional
ablation of Sox2 in the brain were also shown to be partially
mediated by aberrant SHH signaling [6]. Additional studies
revealed that SOX2 co-localized with the ATP-dependent histone
remodeler CHD7 in NPCs [30]. Thus, interactions with chroma-
tin modifiers or other epigenetic regulators may also be critical for
binding site selection and establishment of NPC-specific gene
expression programs in response to particular signals.
Recent data showed that SOX2 functions as a pioneer factor in
ESCs by marking a subset of genes for activation by other SOX
family members, namely SOX4 in the B-cell lineage, SOX3 in
NPCs and SOX11 in immature neurons [17,18]. Interestingly, the
POU factor Brn5, like Sox11, is expressed in differentiated cell
in gene expression between ESCs and NPCs of a transcription factor that recognizes the corresponding motif on the right. Scale bars: Left, fold gene
expression change of transcription factors between ESCs (blue) and NPCs (yellow); Right, change in rank of TRANSFAC motifs between SOX2-OCT4
bound regions (blue) and SOX2-BRN2 bound regions (yellow). p-value reflects correlation of motif enrichment and gene expression of transcription
factors which can recognize the motifs by a Monte-Carlo analysis. (B, C) Ingenuity Pathway Analysis to visualize the functional interconnection among
genes associated with SOX2-BRN2 regions that also contain either an NF-I or RFX motif.
doi:10.1371/journal.pgen.1003288.g006
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types in the CNS and thought to play a role in regulating cell state
[126–130], thus elucidation of BRN5 targets in these cells may
reveal another layer of SOX-POU regulation of neurogenesis.
Taken together, these data suggest that transitions in SOX-POU
partners regulate the earliest stages of development through
terminal differentiation. Ultimately, characterization of combina-
torial interactions among transcription factors and chromatin
regulators at distal enhancers will be central to understanding




ChIP-Seq and Affymetrix microarray data are deposited on
GEO database under the accession numbers GSE38850 and
GSE35496.
Cell growth and culture conditions
C57/BL6-129JAE (V6.5) mouse embryonic stem cells were
cultured in as described [34]. Neural progenitors were derived via
in vitro differentiation from V6.5 ESCs as described [43] and
cultured on 15 mg/ml polyornithine and 1 mg/ml laminin in N3
medium, supplemented with 5 ng/ml bFGF, 20 ng/ml EGF, and
1 mg/ml laminin. In the presence of growth factors the vast
majority of these cells can be labeled homogenously with
antibodies against NESTIN, SOX2, and PAX6. Upon growth
factor withdrawal, the cells differentiate into TUJ1-positive
neurons.
Chromatin immunoprecipitation (ChIP) and library
preparation
ChIP in NPCs was performed as described previously [131].
Briefly, approximately 56108 cells were cross-linked and chroma-
tin fractions were sheared by sonication. ChIP-enriched and input
DNA were purified and genomic libraries were prepared using the
ChIP-Seq Sample Prep Kit (Illumina 1003473) according to the
manufacturers protocol (Illumina 11257047) for selecting library
fragments between 200 and 350 bp. Samples were run using the
GA2X genome sequencer (SCS v2.6, pipeline 1.5).
For ChIP in ESCs, and in TetO-Brn2 cells and control cells were
cross-linked and harvested as above. Approximately 56107
formaldhyde-crosslinked cells were lysed and as above on an IP-
Star (Diagenode). Chromatin was sonicated on the Bioruptor
(Diagenode) to an average size of 0.2–1 kb. ChIP was performed on
chromatin from approximately 5 million cells with 3 mg of antibody
(above) using the IP-Star Automated System (Diagenode) and 2.5%
of chromatin was used for each whole cell extract (WCE). Following
reversal of crosslinks, sample and WCE DNA was purified. ChIP
and WCE DNA was dissolved in water and barcoded genomic
libraries were prepared using the TruSeq DNA Sample Prep Kit
(Illumina) and multiplexed on the HiSeq 2000 (Illumina).
ChIP antibodies
Antibodies used in ChIP experiments are as follows: SOX2 (R
and D Systems AF2018 goat polyclonal); BRN2 (Santa Cruz
Biotechnology sc-6029 goat polyclonal); H3 (rabbit polyclonal
Abcam ab1791) H3K4me1 (rabbit polyclonal Abcam ab8895);
H3K27Ac (rabbit polyclonal Abcam ab4729).
ChIP–seq analysis pipeline
Images acquired from the Illumina/Solexa sequencer were
processed using the bundled Solexa image extraction pipeline.
Sequences were aligned using Bowtie (http://bowtie-bio.
sourceforge.net/index.shtml) using murine genome NCBI Build
36 (UCSC mm8) as the reference genome with default settings for
mismatch tolerance and non-unique mapping events. Mapped
reads were analyzed as described [16]. Briefly, sequence reads
were extended 200 bp for transcription factors and 400 bp for
histone modifications and allocated in 25 bp bins. Statistically
significant enriched bins were identified using a Poissonian
background model, with a p-value threshold of 1028 to minimize
false positives. We then used an empirical background model
(whole cell extracts (WCE) for transcription factors or pan-histone
histone H3 ChIP-Seq (H3) for chromatin marks) that requires bins
to be enriched relative to background to eliminate non-random
enrichment. Replicate datasets were combined and analyzed in
one batch. Previously published datasets for enhancer associated
histone marks were analyzed as described [34,132]. SOX2, BRN2,
and OCT4 enriched regions within 1 kb of a TSS were assigned to
the associated gene, while bound enhancers were identified as
regions that overlap H4K4me1 and/or H3K27Ac regions that are
.1 kb from a TSS [34] and were assigned to the nearest gene
using the GREAT algorithm for gene ontology studies and using
the Galaxy web tool for all other analyses.
ChIP–enrichment plots
ChIP–seq plots for individual genes were generated using the
UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/
hgGateway).. wig files were generated from ChIP-Seq reads and
density was normalized to reads-per-million. Published datasets
were used to correlate SOX2 bound regions to histone
modification patterns for enhancer analysis [34,132].
Comparison of ChIP–seq datasets
We used a 1-bp minimum cutoff for the overlap between
regions to define common genomic targets, as described through-
out the manuscript to define co-bound SOX2-POU sites and sites
occupied by SOX2 or POU factors across cell types. Correlation
of ChIP-Seq datasets in figure S1 was performed using a similarity
metric based on a correlation coefficient [133]. This analysis
generates a correlation coefficient between zero and one reflecting
the similarity of genomic regions occupied in two datasets.
RNA isolation and microarray analysis
RNA was isolated using Trizol reagent (Invitrogen) according to
the manufacturer’s protocol and DNAse treated using the DNA-
Free RNA kit (Zymo Research R1028). Samples were then
prepared for Affymetrix GeneChip Expression Array analysis.
5 mg total RNA was used to prepare biotinylated cRNA according
to the manufacturer’s protocol (Affymetrix One Cycle cDNA
Synthesis Kit). Samples were prepared for hybridization, hybrid-
ized to arrays, and washed according the Affymetrix hybridization
manual using the Affymetrix GeneChip Hybridization, Wash and
Stain Kit. GeneChip arrays (Mouse 430) were hybridized in a
GeneChip Hybridization Oven at 45uC for 16 hours at 60 RPM.
Arrays were scanned on a GeneChip Scanner 3000 and images
were extracted and analyzed using GeneChip Operating Software
v1.4.
To define expression levels of genes linked to bound promoters
and enhancers, and to define fold change of expression levels of
transcription factors linked to enriched TRANSFAC motifs
between ESCs and NPCs, biological replicates were analyzed
using the Affymetrix GCOS program and the mean intensity for
each probe across three arrays was calculated. Maximum probe
mean values for each gene were taken as gene expression levels.
Box and Violin plots were constructed depicting median values as
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the center line, and bottom and top of the box representing the
25th and 75th percentiles, respectively. Whiskers depict+1.5*IQR
(interquartile range) for top, 21.5*IQR for the bottom. To define
differentially expressed genes, array data was RMA normalized
using updated annotation from the BrainCDF the site and
remapped from Ensembl Gene ID to Gene Name using Biomart
table. For finding differentially expressed (DE) genes, the biological
replicates were subjected to moderated welch test (MWT). Genes
were called differentially expressed if the MWT FDR,0.05 and
the fold change of the mean of the replicates was more than 1.5
fold up or down.
Gene ontology
Gene ontology analysis was performed using GOSTAT (http://
gostat.wehi.edu.au/cgi-bin/goStat.pl) for genes linked to SOX2
bound promoters or the GREAT algorithm [134] (http://great.
stanford.edu/) for regions associated with SOX2 bound enhanc-
ers. GOSTAT was performed using the mgi (mouse) GO
annotation database for promoter-associated regions. Since
GREAT analysis requires inputs in the mm9 genome build, lift-
over of mm8 called regions was performed using the Galaxy web
tool prior to input into GREAT (main.g2.bx.psu.edu/). In general,
terminal ‘‘GO Biological Process’’ terms were presented in figures
to maximize the specificity of the information presented. In some
cases terminal terms contained few genes and were thus
misleading, so more informative parent terms encompassing less
specific but more relevant descriptions of biological processes are
presented.
De novo motif enrichment analysis
MEME (meme.sdsc.edu/) [135] was used to find DNA
sequences enriched in SOX2-, OCT4-, and BRN2-bound regions
in ESCs and NPCs. Plus/minus 75 base pairs surrounding a subset
of the highest peaks of enrichment for each factor (minimum peak
height 100 for SOX2, 148 for OCT4, or 225 for BRN2) were
input into MEME and motif logos were generated from obtained
position weight matrices.
Generation of inducible Brn2 ESC lines
Brn2 inducible ESCs were generated using the ‘‘flp-in’’ system
described previously [136]. Briefly, a single copy of a tetracycline
inducible mouse Brn2 cDNA were flipped into the Col1a1 locus of
KH2 ESCs harboring an M2-rtTA gene in the Rosa26 locus.
ESC differentiation
Inducible Brn2 and control (KH2) ESCs were passaged off
feeders and cultured in ESC medium with 2 mg/ml Dox. Twenty-
four hours after passage, cells were culture in N2B27 (without
Vitamin A) media without LIF or serum for the duration of the
experiment [137]. Gene expression for differentiation markers was
assayed by quantitative Real-Time PCR at 24-hour intervals. For
immunostaining, cells were fixed with 4% paraformaldehyde in
PBS and stained with anti-Nestin (Developmental Hybridoma
Bank) and DAPI.
Quantitative real-time PCR
Trizol-isolated RNA from three biologically independent
samples was purified, DNAse treated (DNA free RNA Kit,
Zymo Research) and reverse transcribed using a First Strand
Synthesis Kit (Invtirogen). cDNA was analyzed in triplicate for
each biological sample by quantitative PCR using an ABI
Prism 7000 (Applied Biosystems) with Platinum SYBR green
qPCR SuperMix-UDG with ROX (Invitrogen). All primers
used in this study are listed in Table S11. Data were extracted
from the linear range, and the standard curve method was used
to obtain relative expression values. Technical replicates were
averaged and then biological replicates were averaged.
Statistical significance was determined using Graphpad Prism
to perform an ANOVA with Bonferroni Correction for
multiple testing.
Definition of SOX2-BRN2-bound H3K4me1 and H3K27Ac
Regions in TetO-Brn2 cells
Regions of SOX2-BRN2 co-occupancy in TetO-Brn2 cells were
defined as above. To define regions of differential chromatin state
between TetO-Brn2 and control cells, we first compared
H3K4me1 enrichment in these cells to define regions common
to both cell types or unique to one or the other. Common regions
were merged and treated as one enhancer if detected in both cell
types. A similar analysis was performed for H3K27Ac enrichment.
SOX2-BRN2 regions were then compared to regions of
H3K4me1 and H3K27Ac in order to define SOX2-BRN2
binding events that resulted in changes in chromatin state between
TetO-Brn2 cells and controls.
Identification of DNA binding motifs within SOX2-bound
regions
100 base pair windows around the max peak of SOX2-bound
regions (in ESCs and NPCs) regions were analyzed for the
presence of overrepresented DNA binding motifs. Similarly, 150
base pair windows around the midpoints between the max peaks
of SOX2 and OCT4 or BRN2 (in ESCs or NPCs, respectively) in
co-bound regions were analyzed for the presence of overrepre-
sented DNA binding motifs. We used a hypothesis-based approach
to identify known protein-DNA recognition elements enriched in
each dataset. The set of hypotheses are derived from all vertebrate
position-specific scoring matrices (PSSMs) from TRANSFAC
[138] filtered for sufficient information content (IC.8 total bits).
As many of these motifs are redundant, we clustered them based
on pairwise distance by KL-divergence of the PSSMs using
Affinity Propagation. The TAMO programming environment
[139] was used to store the PSSMs and score sequences. We used
two approaches to identify overrepresented motifs. All motifs
discussed in the paper were found by both methods except for
M00145 in SOX2 bound sites in NPCs which was only found by
the first approach described below.
In the first approach, we determined whether motifs were
overrepresented in a foreground set of all bound regions (SOX2-
bound or SOX2-POU co-bound, depending on the analysis)
compared to a background set of randomly generated sequences
which matched the GC content of the foreground using the Mann-
Whitney-Wilcoxon (MWW) ranked sum test. For each indepen-
dent motif test, sequences were ranked by the maximum motif
score in each sequence (across all k-mers in the sequence for a
motif of width k). This ranked list was used to compute the U
statistic for the foreground set from which we computed a p-value
and applied a Benjamini-Hochberg multiple hypothesis correc-
tion. Because many motifs in the databases are very similar to each
other, we present the motif within each cluster with the most
significant p-value.
In the second approach, we determined whether motifs were
overrepresented in a foreground set of 1,000 randomly selected
bound regions compared to a background set of randomly
generated sequences matching the GC content of the foreground
using THEME [140]. A b value of 0.7 and 5-fold cross-validation
(CV) were used as THEME parameters. Statistical significance of
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the CV-error was calculated using randomization of 25 trials and
multiple hypothesis corrected using the Benjamini-Hochberg
procedure. As in the MWW tables, we present the motif within
each cluster with the most significant p-value.
Genome-wide distances between SOX2 and cell-type-
specific POU factors
Distances between SOX2 bound sites and cofactor bound sites
in ESCs and NPCs were calculated as follows. Overlapping
regions of SOX2 and POU factors were defined as regions with at
least 1-bp of overlap. Peaks from these overlapping regions were
then used to define distances between the bound factors. In
particular, we calculated distances between SOX2-BRN2 site
pairs (NPCs), and SOX2-OCT4 site pairs (ESCs). Site pairs were
defined by matching each SOX2 bound site to the closest cofactor
bound site within 200 bases. Distance was calculated as the
cofactor chromosomal coordinate subtracted from the SOX2
chromosomal coordinate.
Analysis of spacing between motif matches
Spacing between SOX and OCT sites was determined using a
motif-based approach to determine specific spatial arrangement of
the motifs in SOX2-OCT4 (ESCs) and SOX2-BRN2 (NPCs) co-
bound regions. Max motif scores were calculated as described
above and normalized as in Equation 1. Motif matches to SOX
were defined as normalized scores greater than 0.85 to a general
SOX TRANSFAC matrix, M01308. Similarly, OCT family motif
matches were defined as normalized scores greater than 0.85 to a
general OCT TRANSFAC matrix, M00342. For each sequence i




calculated. Spacing was defined as the number of base positions
between the OCT4 and SOX2 motif matches relative to the
SOX2 motif match. OCT-SOX motif pairs were associated with
the previously defined ‘‘canonical’’, ‘‘order’’, ‘‘diverging’’, and
‘‘converging’’ orientations [86].
Gene expression/motif enrichment heat maps
The Mann-Whitney Z-score test result was used to rank all
vertebrate TRANSFAC motifs in order of enrichment for SOX2
and OCT4 bound regions in ESCs, and SOX2 and BRN2 bound
regions in NPCs. The change in rank (DRank) from ESC SOX2-
OCT4 bound regions to SOX2-BRN2 bound regions was
determined for each motif. Motifs were filtered to include only
motifs with a rank less than or equal to 200 in the two ranked lists.
Gene expression fold change was determined for each transcrip-
tion factor associated with at least one TRANSFAC motif. After
assigning a pseudocount of 1 to the normalized Affymetrix gene
expression values for each transcription factor at the ESC and
NPC stages, the log (base 2) of the fold change was calculated.
Motifs were mapped to associated transcription factors according
to the vertebrate all profile accessible on ExPlain 3.0 containing
656 motifs. The TF with the fold change that best agreed with the
DRank of the associated motif was chosen as the ‘representative’
factor for the motif (for instance, if DRank was negative, the
associated transcription factor that had the most negative log-
transformed fold change was chosen.) Scaled motif DRank values
and the associated log-transformed gene expression fold change
values were sorted in order of log-transformed gene expression fold
change, and viewed in a heatmap (Spotfire, TIBCO). Only motifs
that had associated transcription factor expression values were
considered.
Agreement between DRank of motif and expression fold-
change of associated factor
A spearman correlation coefficient was calculated between the
DRank values of the motifs and the expression-fold change of their
associated transcription factors. This required each motif to be
associated with a single transcription factor. In the case where
multiple transcription factors are known to bind a single motif, the
TF was selected as described in the previous section. The
significance of the spearman correlation coefficient was assessed
by a Monte-Carlo algorithm. The input to the Monte-Carlo
algorithm was a table in which each row of the first column was a
motif and each row of the second column was the set of
transcription factors known to bind the motif. The column
containing the motifs was randomly permuted 100,000 times
(thereby randomizing the associations of transcription factors to
motifs), and the process of selecting a single transcription factor to
be associated with each motif was repeated. After associating each
motif with a single random transcription factor, the spearman
correlation between the DRank of the motifs and the log-fold-
change in expression of the transcription factors was computed.
The fraction of randomized tables that produced a higher
spearman correlation than the original table was reported as the
p-value. Only motifs for which the rank in either the SOX2-
OCT4 list or the SOX2-BRN2 list was in the top 200 were used.
The motifs also had to have at least one associated transcription
factor for which gene expression data was available.
Target gene networks
Genomic intervals corresponding to enriched transcription
factor binding motifs in SOX2-BRN2 bound regions were
determined. The single nearest gene to a given region was
determined using the GREAT algorithm. Genes associated with a
motif having a motif similarity score of equal to or greater than
0.85 (439 NF-I motif regions and 251 RFX motif regions) were
used to generate a non-redundant target gene list. This gene list
was then used as the input for Ingenuity Pathway Analysis.
Ingenuity recognized 431 NF-I associated genes and 249 RFX
associated genes. Overlap of genomic regions containing motif
sequences was performed using Galaxy.
Supporting Information
Figure S1 Comparison of SOX2 ChIP-Seq datasets in ESCs
and NPCs. (A) Correlation between published and replicate
ChIP-Seq datasets. (B–D) Overlap of SOX2-bound regions in
ESCs (blue) and NPCs (red) (B) All regions; (C) TSS-associated
regions within 1 kb of an annotated TSS; (D) Genes associated
with TSS-associated regions. If multiple genes were associated
with a single SOX2-bound region, all genes were included in this
list. Increase in overlap as compared to (C) reflects SOX2 binding
at distinct sites within the same promoter in ESCs compared to
NPCs.
(EPS)
Figure S2 Overlap of SOX2-bound enhancers reveals SOX2
occupies distinct enhancers of the same gene in ESCs and NPCs.
(A) Overlap of enhancer-associated SOX2-bound regions in
ESCs and NPCs. (B) Overlap of nearest gene to SOX2-bound
enhancers in ESCs and NPCs. Increase in overlap results from
distinct enhancer regions mapping to the same gene being
occupied by SOX2 in ESCs as compared to NPCs. (C, D)
Overlap of genes linked to SOX2-bound promoters and
enhancers in ESCs (C) and NPCs (D). By including the genes
lined to SOX2-bound enhancers, knowledge of the network
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controlled by SOX2 increased 3.3 fold (3,113 added genes) and 1.4
fold (2,942 added genes) in ESCs and NPCs, respectively. (E) Pie
chart depicting fractions of genes associated with SOX2-bound
poised enhancers in ESCs which become associated with SOX2-
bound poised enhancers in NPCs (purple), with SOX2-bound active
enhancers in NPCs (green), or neither (blue). If a gene gained both a
poised and active enhancer, it was grouped with active genes. p-
values reflect the probability, based on a cumulative hypergeometric
distribution, of obtaining by chance an overlap as high as or higher
than that which was observed. (F) Expression of genes linked to
SOX2-bound poised enhancers in ESCs (left, blue) and the subsets
that become associated with SOX2-bound poised enhancers (center,
red) or with SOX2-bound active enhancers (right, red) in NPCs. If a
gene gained both a poised and active enhancer, it was grouped with
active genes. * reflects p-value,0.0001, unpaired T-test, two tailed.
y-axis reflects relative gene expression level within the indicated cell
type.
(EPS)
Figure S3 Comparison of SOX2-POU bound sites in ESCs
and NPCs. (A) Fraction of total start sites or total marked
enhancers associated with BRN2 in NPCs. (B) MEME motif
analysis of highest enriched ChIP regions for OCT4 in ESCs
and BRN2 in NPCs, demonstrating the similarity in their motif
preference. (C) Venn diagram reflecting overlap of bound
regions of OCT4 in ESCs compared to BRN2 in NPCs (D–F)
Venn diagrams depicting overlap of SOX2 and OCT4 (D) All
bound regions; (E) Genes associated with TSS associated
regions; (F) H3K4me1 and/or H3K27Ac marked enhancers.
(G) Gene plot of the Oct4 (Pou5f1) locus, a known SOX2-OCT4
target. y-axis corresponds to reads per million. Genomic
positions reflect NCBI Mouse Genome Build 36 (mm8). Gray
boxes indicate regions of SOX2-OCT4 co-occupancy. * denotes
known enhancer region. (H–I) Venn diagrams depicting overlap
of SOX2 and BRN2 in NPCs (H) All bound regions; (I) Genes
associated with TSS associated regions; (J) H3K4me1 and/or
H3K27Ac marked enhancers. (K) Gene plots of the Sox2 and
Nestin loci, which contain known SOX2-BRN2 target enhancers.
y-axis corresponds to reads per million. Genomic positions
reflect NCBI Mouse Genome Build 36 (mm8). Gray boxes
indicate regions of SOX2-BRN2 co-occupancy. * denotes
known enhancer region.
(EPS)
Figure S4 Characterization of TetO-Brn2 inducible system. (A)
Schematic of transgenic system for inducible expression of Brn2
from the Col1A1 locus (adapted from [141]). (B) qRT-PCR time
course in control (gray) and Brn2 induced (black) differentiating
ESCs. y-axis represents relative expression normalized to Gapdh in
3 biological replicates, measured in triplicate. * denotes p-
value,0.05, * denotes p-value,0.01 based on ANOVA with
Bonferroni correction. (C) ESC lines were exposed to doxycycline
and after 24 hrs. the medium was replaced with N2B27 medium.
Cells were harvested after 24 hrs. in N2B27 and represented the
day 1 time point. (D) Phase contrast images of control and Brn2
inducible ESCs at day 2 of differentiation used for ChIP-Seq
analyses. (E) Quantification of BRN2 and SOX2 bound regions
that map within 1 kb of annotated TSSs and those which are distal
to TSSs in TetO-Brn2 cells. (F, G) Metagene analysis within 701
regions depicted in Figure 4C, depicting higher ChIP-Seq density
in SOX2 day 2 ChIP compared to SOX2 ESC ChIP (F) and in
BRN2 day 2 ChIP compared to OCT4 ESC ChIP (G). y-axis
represents WCE-corrected average reads per million in indicated
datasets.
(EPS)
Figure S5 Examples of SOX-OCT composite motifs in the four
possible configurations. Nn between the SOX and OCT motifs
reflects the variability of the spacer between these motifs at target
loci, where n can be any number greater than or equal to zero.
Blue boxed motif represents canonical SOX-OCT motif preferred
by SOX2-OCT4 in ESCs when n=1. Red boxed motif represents
SOX-OCT configuration utilized by SOX2-BRN2 more fre-
quently then SOX2-OCT4 when n=5.
(EPS)
Table S1 ChIP-Seq bound regions for all experiments. ChIP-
Seq bound regions called for SOX2 and OCT4 in ESCs, SOX2
and BRN2 in NPCs, and SOX2, BRN2 H3K4me1, and
H3K27Ac in TetO-Brn2 and control cells.
(XLSX)
Table S2 Bound Promoters and Enhancers for ChIP-Seq
Experiments. Bound promoters, active enhancers, and poised
enhancers for SOX2 and OCT4 in ESCs, and SOX2 and BRN2
in NPCs.
(XLSX)
Table S3 GOstat gene ontology analysis of SOX2-bound
promoters. Full lists of GOstat gene ontology IDs enriched in
SOX2-bound promoters in ESCs and NPCs.
(XLSX)
Table S4 Microarray gene expression data in ESCs and NPCs.
(XLSX)
Table S5 GREAT analysis of SOX2-bound enhancers in ESCs.
Full lists of GREAT terms enriched in regions associated with
active and poised enhancers occupied by SOX2 in ESCs.
(XLSX)
Table S6 GREAT analysis of SOX2-bound enhancers in NPCs.
Full lists of GREAT terms enriched in regions associated with
active and poised enhancers occupied by SOX2 in NPCs.
(XLSX)
Table S7 Hypothesis-driven motif search in SOX2-bound
regions in NPCs. Mann-Whitney U test and THEME results for
TRANSFAC motifs enriched in SOX2 regions in NPCs.
(XLSX)
Table S8 GREAT analysis of SOX2-BRN2-co-bound enhanc-
ers in NPCs. Full lists of GREAT terms enriched in regions
associated with active and poised enhancers occupied by BRN2 in
NPCs and with active and poised enhancers occupied by SOX2-
BRN2 in NPCs.
(XLSX)
Table S9 GREAT analysis of BRN2-bound regions common to
TetO-Brn2 cells and NPCs, and SOX2-BRN2-co-bound regions
in TetO-Brn2 cells. Full lists of GREAT terms enriched in regions
bound by BRN2 in both day 2 TetO-Brn2 cells and in NPCs, and
regions co-bound by SOX2-BRN2 in day 2 differentiating TetO-
Brn2 cells which are not bound by OCT4 or SOX2 in ESCs or
SOX2 in control cells.
(XLSX)
Table S10 Hypothesis-driven motif search in SOX2-BRN2-co-
bound regions in NPCs. Mann-Whitney U test and THEME
results for TRANSFAC motifs enriched in SOX2-BRN2 regions
in NPCs.
(XLSX)
Table S11 qRT-PCR primers used to assay for gene expression
in TetO-Brn2 and control cells.
(XLSX)
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
PLOS Genetics | www.plosgenetics.org 16 February 2013 | Volume 9 | Issue 2 | e1003288
Acknowledgments
We thank Alla Leshinsky, Richard Cook, and Charlie Whitaker of the
Koch Institute for Integrated Cancer Research; Jennifer Love and Sumeet
Gupta of the Whitehead Institute; and Stuart Levine of the MIT
Department of Biology for high-throughput sequencing support. We thank
Bingbing Yuan of the Whitehead Institute and Avanti Shrikumar of the
Boyer lab for bioinformatics support; Christopher J. Lengner and Jong-Pil
Kim for assistance in gene targeting; Menno P. Creyghton for helpful
discussions; and David Orlando, Garret Frampton, and Richard A. Young
for generously providing computational tools for ChIP–seq analysis.
Author Contributions
Conceived and designed the experiments: MAL RJ LAB. Performed the
experiments: MAL CWN JAW AWC KKT. Analyzed the data: MAL
CWN JAW AWC. Contributed reagents/materials/analysis tools: AWC
EF. Wrote the paper: MAL LAB.
References
1. Young RA (2011) Control of the Embryonic Stem Cell State. Cell 144: 940–
954.
2. Holmberg J, Perlmann T (2012) Maintaining Differentiated Cellular Identity.
Nature Reviews Genetics 13: 429–439.
3. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent
Cell Lineages in Early Mouse Development Depend on Sox2 Function. Genes
& Development 17: 126.
4. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. (2007)
Pluripotency Governed by Sox2 Via Regulation of Oct3/4 Expression in
Mouse Embryonic Stem Cells. Nature Cell Biology 9: 625–635.
5. Miyagi S, Masui S, Niwa H, Saito T, Shimazaki T, et al. (2008) Consequence
of the Loss of Sox2 in the Developing Brain of the Mouse. FEBS Letters 582:
2811–2815.
6. Favaro R, Valotta M, Ferri ALM, Latorre E, Mariani J, et al. (2009)
Hippocampal Development and Neural Stem Cell Maintenance Require
Sox2-Dependent Regulation of Shh. Nature Neuroscience 12: 1248–
1256.
7. Kamachi Y, Sockanathan S, Liu Q, Breitman M, Lovell-Badge R, et al. (1995)
Involvement of Sox Proteins in Lens-Specific Activation of Crystallin Genes.
The EMBO Journal 14: 3510.
8. Kiernan AE, Pelling AL, Leung KKH, Tang ASP, Bell DM, et al. (2005) Sox2
Is Required for Sensory Organ Development in the Mammalian Inner Ear.
Nature 434: 1031–1035.
9. Okubo T, Pevny LH, Hogan BLM (2006) Sox2 Is Required for Development
of Taste Bud Sensory Cells. Genes & Development 20: 2654.
10. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, et al. (2008) Sox2
Is Important for Two Crucial Processes in Lung Development: Branching
Morphogenesis and Epithelial Cell Differentiation. Developmental Biology
317: 296–309.
11. Domyan ET, Ferretti E, Throckmorton K, Mishina Y, Nicolis SK, et al. (2011)
Signaling through Bmp Receptors Promotes Respiratory Identity in the
Foregut Via Repression of Sox2. Development 138: 971–981.
12. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, et al. (2011) Sox2+ Adult
Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival
of Mice. Cell Stem Cell 9: 317–329.
13. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core
Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells. Cell
122: 947–956.
14. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. (2008) Integration of External
Signaling Pathways with the Core Transcriptional Network in Embryonic Stem
Cells. Cell 133: 1106–1117.
15. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. (2006) The Oct4 and
Nanog Transcription Network Regulates Pluripotency in Mouse Embryonic
Stem Cells. Nature Genetics 38: 431–440.
16. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. (2008)
Connecting Microrna Genes to the Core Transcriptional Regulatory Circuitry
of Embryonic Stem Cells. Cell 134: 521–533.
17. Bergsland M, Ramsko¨ld D, Zaouter C, Klum S, Sandberg R, et al. (2011)
Sequentially Acting Sox Transcription Factors in Neural Lineage Develop-
ment. Genes & Development 25: 2453–2464.
18. Liber D, Domaschenz R, Holmqvist PH, Mazzarella L, Georgiou A, et al.
(2010) Epigenetic Priming of a Pre-B Cell-Specific Enhancer through Binding
of Sox2 and Foxd3 at the ESC Stage. Cell Stem Cell 7: 114–126.
19. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007)
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined
Factors. Cell 131: 861–872.
20. Takahashi K, Yamanaka S (2006) Induction of Pluripotent Stem Cells from
Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126:
663–676.
21. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In Vitro
Reprogramming of Fibroblasts into a Pluripotent Es-Cell-Like State. Nature
448: 318–324.
22. Buganim Y, Faddah DA, Cheng AW, Itskovich E, Markoulaki S, et al. (2012)
Single-Cell Expression Analyses During Cellular Reprogramming Reveal an
Early Stochastic and a Late Hierarchic Phase. Cell 150: 1209–1222.
23. Temple S, Alvarez-Buylla A (1999) Stem Cells in the Adult Mammalian
Central Nervous System. Current Opinion in Neurobiology 9: 135–141.
24. Temple S (2001) The Development of Neural Stem Cells. Nature 414: 112–
117.
25. Suh H, Consiglio A, Ray J, Sawai T, D’Amour KA, et al. (2007) In Vivo Fate
Analysis Reveals the Multipotent and Self-Renewal Capacities of Sox2+ Neural
Stem Cells in the Adult Hippocampus. Cell Stem Cell 1: 515–528.
26. Bylund M, Andersson E, Novitch BG, Muhr J (2003) Vertebrate Neurogenesis
Is Counteracted by Sox1–3 Activity. Nature Neuroscience 6: 1162–1168.
27. Graham V, Khudyakov J, Ellis P, Pevny L (2003) Sox2 Functions to Maintain
Neural Progenitor Identity. Neuron 39: 749–765.
28. Bani-Yaghoub M, Tremblay RG, Lei JX, Zhang D, Zurakowski B, et al. (2006)
Role of Sox2 in the Development of the Mouse Neocortex. Developmental
Biology 295: 52–66.
29. Le N, Nagarajan R, Wang JYT, Araki T, Schmidt RE, et al. (2005) Analysis of
Congenital Hypomyelinating Egr2lo/Lo Nerves Identifies Sox2 as an Inhibitor
of Schwann Cell Differentiation and Myelination. Proc Natl Acad Sci USA
102: 2596.
30. Engelen E, Akinci U, Bryne JC, Hou J, Gontan C, et al. (2011) Sox2
Cooperates with Chd7 to Regulate Genes That Are Mutated in Human
Syndromes. Nature Genetics 43: 607–611.
31. Buecker C, Wysocka J (2012) Enhancers as Information Integration Hubs in
Development: Lessons from Genomics. Trends in Genetics 6: 276–284.
32. Bulger M, Groudine M (2011) Functional and Mechanistic Diversity of Distal
Transcription Enhancers. Cell 144: 327–339.
33. Ong CT, Corces VG (2011) Enhancer Function: New Insights into the
Regulation of Tissue-Specific Gene Expression. Nature Reviews Genetics 12:
283–293.
34. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, et al. (2010)
Histone H3k27ac Separates Active from Poised Enhancers and Predicts
Developmental State. Proc Natl Acad Sci USA 107: 21931.
35. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, et al. (2009)
Histone Modifications at Human Enhancers Reflect Global Cell-Type-Specific
Gene Expression. Nature 459: 108–112.
36. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. (2007) Distinct
and Predictive Chromatin Signatures of Transcriptional Promoters and
Enhancers in the Human Genome. Nature Genetics 39: 311–318.
37. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, et al. (2010) A
Unique Chromatin Signature Uncovers Early Developmental Enhancers in
Humans. Nature 470: 279–283.
38. Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N, et al. (2004) Interplay
of Sox and Pou Factors in Regulation of the Nestin Gene in Neural Primordial
Cells. Molecular and Cellular Biology 24: 8834.
39. Chew JL, Loh YH, Zhang W, Chen X, Tam WL, et al. (2005) Reciprocal
Transcriptional Regulation of Pou5f1 and Sox2 Via the Oct4/Sox2 Complex
in Embryonic Stem Cells. Molecular and Cellular Biology 25: 6031–6046.
40. Jin Z, Liu L, Bian W, Chen Y, Xu G, et al. (2009) Different Transcription
Factors Regulate Nestin Gene Expression During P19 Cell Neural Differen-
tiation and Central Nervous System Development. Journal of Biological
Chemistry 284: 8160–8173.
41. Kondoh H, Kamachi Y (2010) Sox-Partner Code for Cell Specification:
Regulatory Target Selection and Underlying Molecular Mechanisms. The
International Journal of Biochemistry and Cell Biology 42: 391–399.
42. Dailey L, Basilico C (2001) Coevolution of Hmg Domains and Homeodomains
and the Generation of Transcriptional Regulation by Sox/Pou Complexes.
Journal of Cellular Physiology 186: 315–328.
43. Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RDG (1996)
Development of Neuronal Precursor Cells and Functional Postmitotic Neurons
from Embryonic Stem Cells in Vitro. Mechanisms of Development 59: 89–102.
44. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, et al. (2003) The
Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse
Epiblast and Es Cells. Cell 113: 631–642.
45. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional
Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic
Stem Cells. Cell 113: 643–655.
46. Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji
M, et al. (1993) Disruption of Krox-20 Results in Alteration of Rhombomeres 3
and 5 in the Developing Hindbrain. Cell 75: 1199–1214.
47. Sham MH, Vesque C, Nonchev S, Marshall H, Frain M, et al. (1993) The Zinc
Finger Gene Krox20 Regulates Hoxb2 (Hox2.8) During Hindbrain Segmen-
tation. Cell 72: 183–196.
48. Sugo N, Oshiro H, Takemura M, Kobayashi T, Kohno Y, et al. (2010)
Nucleocytoplasmic Translocation of Hdac9 Regulates Gene Expression and
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
PLOS Genetics | www.plosgenetics.org 17 February 2013 | Volume 9 | Issue 2 | e1003288
Dendritic Growth in Developing Cortical Neurons. European Journal of
Neuroscience 31: 1521–1532.
49. Shin J, Bossenz M, Chung Y, Ma H, Byron M, et al. (2010) Maternal Rnf12/
Rlim Is Required for Imprinted X-Chromosome Inactivation in Mice. Nature
467: 977–981.
50. Ostendorff HP, Tursun B, Cornils K, Schluter A, Drung A, et al. (2006)
Dynamic Expression of Lim Cofactors in the Developing Mouse Neural Tube.
Developmental Dynamics 235: 786–791.
51. Grabowski P (2011) Alternative Splicing Takes Shape During Neuronal
Development. Current Opinion in Genetics & Development. 4:388–94
52. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, et al. (2007) A Post-
Transcriptional Regulatory Switch in Polypyrimidine Tract-Binding Proteins
Reprograms Alternative Splicing in Developing Neurons. Genes & Develop-
ment 21: 1636.
53. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, et al. (2012)
Dynamic and Coordinated Epigenetic Regulation of Developmental Transi-
tions in the Cardiac Lineage. Cell 151: 206–220.
54. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, et al. (2011)
Mapping and Analysis of Chromatin State Dynamics in Nine Human Cell
Types. Nature 473: 43–49.
55. Zentner GE, Tesar PJ, Scacheri PC (2011) Epigenetic Signatures Distinguish
Multiple Classes of Enhancers with Distinct Cellular Functions. Genome
Research 21: 1273–1283.
56. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, et al. (2008) A Core Klf Circuitry
Regulates Self-Renewal of Embryonic Stem Cells. Nature Cell Biology 10:
353–360.
57. Tzatzalos E, Smith SM, Doh ST, Hao H, Li Y, et al. (2012) A Cis-Element in
the Notch1 Locus Is Involved in the Regulation of Gene Expression in
Interneuron Progenitors. Developmental Biology. 372(2):217–28
58. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, et al. (2006) Sox2
Is a Dose-Dependent Regulator of Retinal Neural Progenitor Competence.
Genes & Development 20: 1187–1202.
59. Kondoh H, Kamachi Y (2010) Sox-Partner Code for Cell Specification:
Regulatory Target Selection and Underlying Molecular Mechanisms. The
International Journal of Biochemistry & Cell Biology 42: 391–399.
60. Yuan H, Corbi N, Basilico C, Dailey L (1995) Developmental-Specific Activity
of the Fgf-4 Enhancer Requires the Synergistic Action of Sox2 and Oct-3.
Genes & Development 9: 2635.
61. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji M, Norris D, et al.
(1996) A Comparison of the Properties of Sox-3 with Sry and Two Related
Genes, Sox-1 and Sox-2. Development 122: 509.
62. Kamachi Y, Cheah KSE, Kondoh H (1999) Mechanism of Regulatory Target
Selection by the Sox High-Mobility-Group Domain Proteins as Revealed by
Comparison of Sox1/2/3 and Sox9. Molecular and Cellular Biology 19: 107.
63. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P (2010) Peakanalyzer:
Genome-Wide Annotation of Chromatin Binding and Modification Loci.
BMC Bioinformatics 11: 415.
64. Catena R, Tiveron C, Ronchi A, Porta S, Ferri A, et al. (2004) Conserved Pou
Binding DNA Sites in the Sox2 Upstream Enhancer Regulate Gene Expression
in Embryonic and Neural Stem Cells. Journal of Biological Chemistry 279:
41846–41857.
65. Miyagi S, Nishimoto M, Saito T, Ninomiya M, Sawamoto K, et al. (2006) The
Sox2 Regulatory Region 2 Functions as a Neural Stem Cell-Specific Enhancer
in the Telencephalon. Journal of Biological Chemistry 281: 13374–13381.
66. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, et al. (1989)
Expression of a Large Family of Pou-Domain Regulatory Genes in Mammalian
Brain Development. Nature 340: 35–41.
67. Hara Y, Rovescalli AC, Kim Y, Nirenberg M (1992) Structure and Evolution
of Four Pou Domain Genes Expressed in Mouse Brain. Proc Natl Acad Sci
USA 89: 3280.
68. McEvilly RJ, de Diaz MO, Schonemann MD, Hooshmand F, Rosenfeld MG
(2002) Transcriptional Regulation of Cortical Neuron Migration by Pou
Domain Factors. Science 295: 1528.
69. Sugitani Y, Nakai S, Minowa O, Nishi M, Jishage K, et al. (2002) Brn-1 and
Brn-2 Share Crucial Roles in the Production and Positioning of Mouse
Neocortical Neurons. Genes & Development 16: 1760.
70. Lujan E, Chanda S, Ahlenius H, Su¨dhof TC, Wernig M (2012) Direct
Conversion of Mouse Fibroblasts to Self-Renewing, Tripotent Neural
Precursor Cells. Proc Natl Acad Sci USA 109: 2527–2532.
71. Staudt LM, Singh H, Sen R, Wirth T, Sharp PA, et al. (1986) A Lymphoid-
Specific Protein Binding to the Octamer Motif of Immunoglobulin Genes.
Nature 323: 640–643.
72. Phillips K, Luisi B (2000) The Virtuoso of Versatility: Pou Proteins That Flex to
Fit1. Journal of Molecular Biology 302: 1023–1039.
73. Kleinjan DA, Seawright A, Childs AJ, van Heyningen V (2004) Conserved
Elements in Pax6 Intron 7 Involved in (Auto)Regulation and Alternative
Transcription. Developmental Biology 265: 462–477.
74. Friedli M, Barde I, Arcangeli M, Verp S, Quazzola A, et al. (2010) A
Systematic Enhancer Screen Using Lentivector Transgenesis Identifies
Conserved and Non-Conserved Functional Elements at the Olig1 and Olig2
Locus. PLoS ONE 5: e15741. doi:10.1371/journal.pone.0015741
75. Verma-Kurvari S, Savage T, Smith D, Johnson JE (1998) Multiple Elements
Regulate Mash1 Expression in the Developing Cns. Developmental Biology
197: 106–116.
76. Rose MF, Ahmad KA, Thaller C, Zoghbi HY (2009) Excitatory Neurons of the
Proprioceptive, Interoceptive, and Arousal Hindbrain Networks Share a
Developmental Requirement for Math1. Proc Natl Acad Sci USA 106: 22462–
22467.
77. Lai HC, Klisch TJ, Roberts R, Zoghbi HY, Johnson JE (2011) In Vivo
Neuronal Subtype-Specific Targets of Atoh1 (Math1) in Dorsal Spinal Cord.
The Journal of Neuroscience 31: 10859–10871.
78. Honda T, Kobayashi K, Mikoshiba K, Nakajima K (2011) Regulation of
Cortical Neuron Migration by the Reelin Signaling Pathway. Neurochemical
Research 36: 1270–1279.
79. Andreae LC, Peukert D, Lumsden A, Gilthorpe JD (2007) Analysis of Lrrn1
Expression and Its Relationship to Neuromeric Boundaries During Chick
Neural Development. Neural Development 2: 22.
80. Taguchi A, Wanaka A, Mori T, Matsumoto K, Imai Y, et al. (1996) Molecular
Cloning of Novel Leucine-Rich Repeat Proteins and Their Expression in the
Developing Mouse Nervous System. Brain Res Mol Brain Res 35: 31–40.
81. Sano Y, Syuzo-Takabatake A, Nakaya T, Saito Y, Tomita S, et al. (2006)
Enhanced Amyloidogenic Metabolism of the Amyloid Beta-Protein Precursor
in the X11l-Deficient Mouse Brain. Journal of Biological Chemistry 281:
37853–37860.
82. Botquin V, Hess H, Fuhrmann G, Anastassiadis C, Gross MK, et al. (1998)
New Pou Dimer Configuration Mediates Antagonistic Control of an
Osteopontin Preimplantation Enhancer by Oct-4 and Sox-2. Genes &
Development 12: 2073–2090.
83. Nishimoto M, Fukushima A, Okuda A, Muramatsu M (1999) The Gene for the
Embryonic Stem Cell Coactivator Utf1 Carries a Regulatory Element Which
Selectively Interacts with a Complex Composed of Oct-3/4 and Sox-2.
Molecular and Cellular Biology 19: 5453–5465.
84. Ambrosetti DC, Scho¨ler HR, Dailey L, Basilico C (2000) Modulation of the
Activity of Multiple Transcriptional Activation Domains by the DNA Binding
Domains Mediates the Synergistic Action of Sox2 and Oct-3 on the Fibroblast
Growth Factor-4 enhancer. Journal of Biological Chemistry 275: 23387.
85. Reme´nyi A, Lins K, Nissen LJ, Reinbold R, Scho¨ler HR, et al. (2003) Crystal
Structure of a Pou/Hmg/DNA Ternary Complex Suggests Differential
Assembly of Oct4 and Sox2 on Two Enhancers. Genes & Development 17:
2048–2059.
86. Jauch R, Aksoy I, Hutchins AP, Ng CKL, Tian XF, et al. (2011) Conversion of
Sox17 into a Pluripotency Reprogramming Factor by Reengineering Its
Association with Oct4 on DNA. Stem Cells 29: 940–951.
87. Ambrosetti DC, Basilico C, Dailey L (1997) Synergistic Activation of the
Fibroblast Growth Factor 4 Enhancer by Sox2 and Oct-3 Depends on Protein-
Protein Interactions Facilitated by a Specific Spatial Arrangement of Factor
Binding Sites. Molecular and Cellular Biology 17: 6321.
88. Ferraris L, Stewart AP, Kang J, DeSimone AM, Gemberling M, et al. (2011)
Combinatorial Binding of Transcription Factors in the Pluripotency Control
Regions of the Genome. Genome Research 21: 1055–1064.
89. Ng CKL, Li NX, Chee S, Prabhakar S, Kolatkar PR, et al. (2012) Deciphering
the Sox-Oct Partner Code by Quantitative Cooperativity Measurements.
Nucleic Acids Research.
90. Remenyi A, Scholer HR, Wilmanns M (2004) Combinatorial Control of Gene
Expression. Nature Structural and Molecular Biology 11: 812–815.
91. Rochette-Egly C, Germain P (2009) Dynamic and Combinatorial Control of
Gene Expression by Nuclear Retinoic Acid Receptors (RARs). Nuclear
Receptor Signalling 7: e005.
92. Sundrud MS, Nolan MA (2010) Synergistic and Combinatorial Control of T
Cell Activation and Differentiation by Transcription Factors. Curr Opin
Immunol 22: 286–292.
93. Michel D (2010) How Transcription Factors Can Adjust the Gene Expression
Floodgates. Progress in Biophysics and Molecular Biology 102: 16–37.
94. Kim J, Chu J, Shen X, Wang J, Orkin SH (2008) An Extended Transcriptional
Network for Pluripotency of Embryonic Stem Cells. Cell 132: 1049–1061.
95. Yang J, Chai L, Fowles TC, Alipio Z, Xu D, et al. (2008) Genome-Wide
Analysis Reveals Sall4 to Be a Major Regulator of Pluripotency in Murine-
Embryonic Stem Cells. Proc Natl Acad Sci USA 105: 19756–19761.
96. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA (2008) Tcf3 Is an
Integral Component of the Core Regulatory Circuitry of Embryonic Stem
Cells. Genes & Development 22: 746.
97. das Neves L, Duchala CS, Tolentino-Silva F, Haxhiu MA, Colmenares C, et al.
(1999) Disruption of the Murine Nuclear Factor I-a Gene (Nfia) Results in
Perinatal Lethality, Hydrocephalus, and Agenesis of the Corpus Callosum.
Proc Natl Acad Sci USA 96: 11946–11951.
98. Baas D, Meiniel A, Benadiba C, Bonnafe E, Meiniel O, et al. (2006) A
Deficiency in Rfx3 Causes Hydrocephalus Associated with Abnormal
Differentiation of Ependymal Cells. Europena Journal Neuroscience 24:
1020–1030.
99. Ashique AM, Choe Y, Karlen M, May SR, Phamluong K, et al. (2009) The
Rfx4 Transcription Factor Modulates Shh Signaling by Regional Control of
Ciliogenesis. Science Signalling 2: ra70.
100. Alcantara S, Frisen J, del Rio JA, Soriano E, Barbacid M, et al. (1997) Trkb
Signaling Is Required for Postnatal Survival of Cns Neurons and Protects
Hippocampal and Motor Neurons from Axotomy-Induced Cell Death. The
Journal of Neuroscience 17: 3623–3633.
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
PLOS Genetics | www.plosgenetics.org 18 February 2013 | Volume 9 | Issue 2 | e1003288
101. Postigo A, Calella AM, Fritzsch B, Knipper M, Katz D, et al. (2002) Distinct
Requirements for Trkb and Trkc Signaling in Target Innervation by Sensory
Neurons. Genes & Development 16: 633–645.
102. O’Hare MJ, Kushwaha N, Zhang Y, Aleyasin H, Callaghan SM, et al. (2005)
Differential Roles of Nuclear and Cytoplasmic Cyclin-Dependent Kinase 5 in
Apoptotic and Excitotoxic Neuronal Death. The Journal of Neuroscience 25:
8954–8966.
103. Rochet JC (2007) Novel Therapeutic Strategies for the Treatment of Protein-
Misfolding Diseases. Expert Rev Mol Med 9: 1–34.
104. Gritti A, Parati E, Cova L, Frolichsthal P, Galli R, et al. (1996) Multipotential
Stem Cells from the Adult Mouse Brain Proliferate and Self-Renew in
Response to Basic Fibroblast Growth Factor. The Journal of Neuroscience 16:
1091–1100.
105. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, et al. (1999) Distinct
Neural Stem Cells Proliferate in Response to Egf and Fgf in the Developing
Mouse Telencephalon. Developmental Biology 208: 166–188.
106. Qian X, Shen Q, Goderie SK, He W, Capela A, et al. (2000) A Programmed
Sequence of Neuron and Glial Cell Production from Isolated Murine Cortical
Stem Cells. Neuron 28: 69–80.
107. Yasuhara N, Shibazaki N, Tanaka S, Nagai M, Kamikawa Y, et al. (2006)
Triggering Neural Differentiation of ES Cells by Subtype Switching of
Importin-A. Nature Cell Biology 9: 72–79.
108. Iwafuchi-Doi M, Yoshida Y, Onichtchouk D, Leichsenring M, Driever W, et
al. (2010) The Pou5f1/Pou3f-Dependent but SoxB-Independent Regulation of
Conserved Enhancer N2 Initiates Sox2 Expression During Epiblast to Neural
Plate Stages in Vertebrates. Developmental Biology 352(2):354–66.
109. Kim JB, Sebastiano V, Wu G, Arau´zo-Bravo MJ, Sasse P, et al. (2009) Oct4-
Induced Pluripotency in Adult Neural Stem Cells. Cell 136: 411–419.
110. Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I, et al.
(1998) Cooperative Function of Pou Proteins and Sox Proteins in Glial Cells.
Journal of Biological Chemistry 273: 16050.
111. Ghislain J, Charnay P (2006) Control of Myelination in Schwann Cells: A
Krox20 Cis-Regulatory Element Integrates Oct6, Brn2 and Sox10 Activities.
EMBO Rep 7: 52–58.
112. Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, et al. (2006) Klf4
Cooperates with Oct3/4 and Sox2 to Activate the Lefty1 Core Promoter in
Embryonic Stem Cells. Molecular and Cellular Biology 26: 7772–7782.
113. Reiprich S, Kriesch J, Schreiner S, Wegner M (2010) Activation of Krox20
Gene Expression by Sox10 in Myelinating Schwann Cells. Journal of
Neurochemistry 112: 744–754.
114. Nowling TK, Johnson LR, Wiebe MS, Rizzino A (2000) Identification of the
Transactivation Domain of the Transcription Factor Sox-2 and an Associated
Co-Activator. Journal of Biological Chemistry 275: 3810–3818.
115. Williams Jr DC, Cai M, Clore GM (2004) Molecular Basis for Synergistic
Transcriptional Activation by Oct1 and Sox2 Revealed from the Solution
Structure of the 42-Kda Oct1? Sox2? Hoxb1-DNA Ternary Transcription
Factor Complex. Journal of Biological Chemistry 279: 1449–1457.
116. Maniatis T, Falvo J, Kim T, Kim T, Lin C, et al. Structure and Function of the
Interferon-B Enhanceosome; 1998. Cold Spring Harbor Laboratory Press. pp.
609–620.
117. Wang J, Rao S, Chu J, Shen X, Levasseur DN, et al. (2006) A Protein
Interaction Network for Pluripotency of Embryonic Stem Cells. Nature 444:
364–368.
118. Liang J, Wan M, Zhang Y, Gu P, Xin H, et al. (2008) Nanog and Oct4
Associate with Unique Transcriptional Repression Complexes in Embryonic
Stem Cells. Nature Cell Biology 10: 731–739.
119. Van Den Berg DLC, Snoek T, Mullin NP, Yates A, Bezstarosti K, et al. (2010)
An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells. Cell
Stem Cell 6: 369–381.
120. Chambers I, Tomlinson SR (2009) The Transcriptional Foundation of
Pluripotency. Development 136: 2311–2322.
121. Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, et al. (2005) The
Transcription Factor Gene Nfib Is Essential for Both Lung Maturation and
Brain Development. Molecular and Cellular Biology 25: 685–698.
122. Piper M, Barry G, Hawkins J, Mason S, Lindwall C, et al. (2010) NfIA Controls
Telencephalic Progenitor Cell Differentiation through Repression of the Notch
Effector Hes1. The Journal of Neuroscience 30: 9127–9139.
123. Campbell CE, Piper M, Plachez C, Yeh YT, Baizer JS, et al. (2008) The
Transcription Factor NfIX Is Essential for Normal Brain Development. BMC
Developmental Biology 8: 52.
124. Plachez C, Lindwall C, Sunn N, Piper M, Moldrich RX, et al. (2008) Nuclear
Factor I Gene Expression in the Developing Forebrain. Journal of
Computational Neurology 508: 385–401.
125. Blackshear PJ, Graves JP, Stumpo DJ, Cobos I, Rubenstein JLR, et al. (2003)
Graded Phenotypic Response to Partial and Complete Deficiency of a Brain-
Specific Transcript Variant of the Winged Helix Transcription Factor Rfx4.
Development 130: 4539–4552.
126. Okamoto K, Wakamiya M, Noji S, Koyama E, Taniguchi S, et al. (1993) A
Novel Class of Murine Pou Gene Predominantly Expressed in Central Nervous
System. Journal of Biological Chemistry 268: 7449–7457.
127. Andersen B, Schonemann M, Pearse RV, Jenne K, Sugarman J, et al. (1993)
Brn-5 Is a Divergent Pou Domain Factor Highly Expressed in Layer Iv of the
Neocortex. Journal of Biological Chemistry 268: 23390.
128. Cui H, Bulleit RF (1997) Expression of the Pou Transcription Factor Brn-5
Inhibits Proliferation of Ng108-15 Cells. Biochemical and Biophysical Research
Communications 236: 693–696.
129. Cui H, Bulleit RF (1998) Expression of the POU Transcription Factor Brn-5 Is
an Early Event in the Terminal Differentiation of CNS Neurons. Journal of
Neuroscience Research 52: 625–632.
130. Wu R, Jurek M, Sundarababu S, Weinstein DE (2001) The Pou Gene Brn-5 Is
Induced by Neuregulin and Is Restricted to Myelinating Schwann Cells.
Molecular and Cellular Neuroscience 17: 683–695.
131. Lee TI, Johnstone SE, Young RA (2006) Chromatin Immunoprecipitation and
Microarray-Based Analysis of Protein Location. Nature Protocols 1: 729–748.
132. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-
Wide Maps of Chromatin State in Pluripotent and Lineage-Committed Cells.
Nature 448: 553–560.
133. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA (2009) Setdb1
Contributes to Repression of Genes Encoding Developmental Regulators and
Maintenance of ES Cell State. Genes & Development 23: 2484.
134. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, et al. (2010) Great
Improves Functional Interpretation of Cis-Regulatory Regions. Nature
Biotechnology 28: 495–501.
135. Bailey TL, Elkan C (1994) Fitting a Mixture Model by Expectation
Maximization to Discover Motifs in Biopolymers. Proc Int Conf Intell Syst
Mol Biol 2: 28–36.
136. Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R (2006) Efficient
Method to Generate Single-Copy Transgenic Mice by Site-Specific Integration
in Embryonic Stem Cells. Genesis 44: 23–28.
137. Ying QL, Stavridis M, Griffiths D, Li M, Smith A (2003) Conversion of
Embryonic Stem Cells into Neuroectodermal Precursors in Adherent
Monoculture. Nature Biotechnology 21: 183–186.
138. Wingender E, Dietze P, Karas H, Knuppel R (1996) Transfac: A Database on
Transcription Factors and Their DNA Binding Sites. Nucleic Acids Research
24: 238–241.
139. Gordon DB, Nekludova L, McCallum S, Fraenkel E (2005) Tamo: A Flexible,
Object-Oriented Framework for Analyzing Transcriptional Regulation Using
DNA-Sequence Motifs. Bioinformatics 21: 3164–3165.
140. Macisaac KD, Gordon DB, Nekludova L, Odom DT, Schreiber J, et al. (2006)
A Hypothesis-Based Approach for Identifying the Binding Specificity of
Regulatory Proteins from Chromatin Immunoprecipitation Data. Bioinfor-
matics 22: 423–429.
141. Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic Expression of
Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial
Tissues. Cell 121: 465–477.
SOX2-POU Factors Occupy Enhancers in ESCs and NPCs
PLOS Genetics | www.plosgenetics.org 19 February 2013 | Volume 9 | Issue 2 | e1003288
